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ABSTRACT
Billions of dollars are spent on diabetes in healthcare each year. Patients with lower socioeconomic-status tend to have poor glycemic control, higher associated diabetic complications,
and higher associated mortality rates. In underserved patients with Type 2 Diabetes, does
utilization of a Diabetes app, compared to previous self-care management and clinic education,
lower the Hemoglobin A1c over a 3-month period? A 3-month scholarly project was conducted
in a small rural town in Virginia with an average median income around $17,000. N=21
participants were selected for the scholarly project. Inclusive criteria consisted of adults aged
19-70 years with a diagnosis of type 2 diabetes for more than 6 months. Participants were
required to have access to iOS/Android cellular devices. Additionally, participants were
requested to complete pre and post self-care management and demographics questionnaires, and
utilize the Diabetes app daily during the 3 month intervention window. After the 3-month
intervention window, particpants had an overall decrease in hemoglobin A1c by (2.34%, p =
.004). Further evidence demonstrated a direct improvement in self-care management techniques
ratings based on average, good, and great with an overall mean increase of 14.3% after the
intervention window. Particpants who scored poor and bad had an overall mean decrease of
21.38% after the intervention period. Mobile-based technology serves to help patients achieve
their target glycemic goals, reduce mortality and morbidity, and promotes more versatile
methods of healthcare delivery compared to traditional interventions and educational methods
such as oral glycemic agents, diabetic class education, and insulin administration to manage
T2DM.
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SECTION ONE: INTRODUCTION
Each year, 327 billion dollars are spent on diabetes in healthcare (American Diabetes
Association [ADA], 2018). Currently, over 30 million people live with Diabetes Mellitus Type 2
(T2DM) in the United States (ADA, 2018). Unfortunately, patients suffering from diabetes often
are non-compliant with recommended medical therapies. Adherence is defined as a person’s
ability to take medication, follow recommended dietary modifications, lifestyle modifications,
and retain close communication between the provider and patient (Perez, Alvarez, Dilla, &
Guillen, 2013). Despite supportive evidence that demonstrates increased compliance and
longevity of patients suffering from T2DM with medication compliance, around 50% of patients
with T2DM are non-complaint with associated medical therapies (Perez et al., 2013). As a
result, hyperglycemia and increased mortality leads to billions of dollars in healthcare services
spent each year (Perez et al., 2013).
Poverty is not only associated with a higher incident of diabetes, it is also associated with
decreased access to diabetic management (Hsu et al., 2012). Patients with low socio-economicstatus tend to have poor glycemic control, higher associated diabetes complications, and higher
mortality rates (Hsu et al., 2012). Various barriers to optimizing care of patients suffering from
T2DM in low-income areas include lack of transportation, limited healthcare access, and medical
costs associated with medical supplies (Hsu et al., 2012). People of low socio-economic status
are more than 50% less likely to receive recommended diabetic checkups (Hsu et al., 2012).
What can be done to solve this problem in the underserved population? How can we
decrease the unequal disparities associated with T2DM in poor communities compared to middle
and high-income class communities? Two of the most commonly associated barriers to effective
management of T2DM are a lack of communication between the patient and provider and failed
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follow-up appointments. Is there a way to help correct this problem? We currently live in a
technological era. In particular, smartphone and devices with mobile app capabilities can be
used to help patients manage chronic illnesses. The vast majority of Americans own cell phones,
accounting for approximately 96% of the United States population (“Cell Phone Facts,” 2019).
Of people with cell phones 81% have smartphone capabilities (“Cell Phone Facts,” 2019).
Whitehead and Seaton (2016) reviewed several studies supporting the usage of mobile apps to
improve symptom management and compliance through self-care management interventions.
The purpose of this scholarly project was to determine if the utilization of the Diabetes app
would decrease the hemoglobin A1c and improve the self-care management techniques in
patients diagnosed with T2DM in the underserved patient population.
Background
Working with the underserved population can serve as a difficult challenge. The
underserved population often have several barriers to face with healthcare. Pulmonary,
cardiovascular, learning disabilities, and poor quality of life are common health disparities within
the underserved population (Hooker, 2013). Diabetes management in the underserved patient
population is disproportionately managed compared to higher socioeconomic classes. In fact,
compliance and treatment failure rates are higher within the underserved patient population
(Hooker, 2013). This unfortunate fact applies to those who suffer from T2DM. What if there
was a way to help bridge this gap in healthcare and avoid this barrier to optimizing care?
Technological advancements have provided revolutionary advancements in medicine. How can
mobile-based technology be utilized to facilitate better healthcare management for the
underserved patient population?
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T2DM requires extensive self-care management techniques for effective disease
management (Beverly, Worley, Court, Prokopakis, & Ivanov, 2016). Fundamentally, effective
communication between patients and providers must consist of continuous care (Beverly et al.,
2016). Recent studies reflect that diabetic self-care communication is directly related to patient
satisfaction, medication compliance, and associated with improved patient outcomes and patient
satisfaction (Beverly et al., 2016). Providers often report one of the biggest barriers to effective
communication with patients is time limitations (Beverly et al., 2016). Interestingly, a recent
study concluded that patients felt shame, guilt, and even embarrassment to report they did not
feel connected with their providers during and after chronic care appointments due to time
constraints (Beverly et al., 2016). However, one benefit of utilizing the Diabetes app was to
break down barriers and optimize effective patient provider communication while improving
participants self-care management techniques for T2DM.
Utilization of the Diabetes app served to improve communication between patients and
providers outside of traditional chronic care visits. An educational hub for patients in the
underserved patient population. It consisted of dietary food options, various exercise regimens,
blood sugar log, diabetic education congruent with the American Diabetes Association (ADA),
and self-care techniques for diabetes management. Increased self-care management techniques
should improve patients’ hemoglobin A1c outside of traditional T2DM chronic care
management. Recent studies supported that even small improvements in patient–provider
communication positively influence self-care adherence for patients with T2DM (Patel, Datye, &
Jesser, 2018).
Lately, technology has transformed the way healthcare is delivered to patients with
T2DM. Technological advancements in the management of T2DM include accurate data
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collection and tracking, online glucose monitoring, improved glucometers, improvement of
diabetic insulin pumps, improvement of access to health information, streaming information
monitors, and a complete expansion of innovative therapies available for patients in the forms of
oral glycemic agents and various insulins. Technology has served as an excellent reservoir for
improving self-care management techniques in patients with T2DM. Technology improves the
self-care management techniques of patients by enabling patients to perform self-blood glucose
monitoring, dietary adherence recommendations, medication adherence, and user platform
discussion forums. The utilization of mobile-based app technology improves barriers to
healthcare access, enhances patient education, and increases patient exposure to self-care
management techniques. Healthcare providers should incorporate the utilization of mobile-based
technology to effectively manage T2DM.
Problem Statement
Research supports that the underserved patient population suffers increased mortality and
morbidity by more than 50% compared to middle- and high-income groups who suffer from
T2DM (Duke, Colaguri, & Colaguri, 2015). Often, the underserved patient population reports a
lack of transportation, limited healthcare access, and a lack of self-care management techniques
as barriers to effectively managing their chronic illnesses. This rural clinic located in Virginia
experiences many of these barriers resulting in decreased self-care management compliance and
unchanged hemoglobin A1c levels.
Purpose of the Project
The purpose of this scholarly project was to determine if utilization of the Diabetes app
would decrease the hemoglobin A1c in patients diagnosed with T2DM in the underserved patient
population and enhance their self-care management techniques. Additionally, the project aimed
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to provide the underserved patient population with full-time access to various educational
resources to improve self-care management techniques.
Clinical Question
In underserved patients with T2DM, does utilization of a Diabetes App, compared to
previous self-care management and clinic education, lower the hemoglobin A1c over a threemonth period?
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SECTION TWO: LITERATURE REVIEW
The purpose of this literature review was to provide insight into the health disparities
within the underserved population with T2DM. This literature review explored the benefits of
utilizing mobile apps to improve self-care management of patients with T2DM resulting in
decreased hemoglobin A1c. Qualitative and quantitative research provided evidence to support
the utilization of mobile apps associated with the clinical management of T2DM. This literature
review evaluated the influence of mobile-based technology and patient self-care management
techniques of T2DM.
Search Strategy
A literature review was conducted to gather data pertaining to the large healthcare
disparity among diabetics within the underserved patient population. Goals of the search set out
to optimize the most relevant data supporting the utilization of mobile-based technology and
diabetic management. A comprehensive database search was conducted using CINAHL,
Pubmed, Medline, and EBSCOhost, and ProQuest. The following keywords and phrases were
utilized during the search: mobile app help manage diabetes, mobile technology effectively
manage chronic illnesses, mobile technology decreases hemoglobin A1c, barriers in underserved
patient populations diabetes management, barriers underserved population healthcare, and
mobile app devices assist healthcare providers to optimize care. Parameters of the literature
search included peer-reviewed studies, clinical case studies, and clinical trials written in the
English language within the past 5 years. The total number of articles reviewed before
application of parameters applied was 40. After inclusion criteria was applied there were 20
remaining articles. Careful attention was taken during this literature search to avoid biased work,
ineffective data, and research studies that contained conflicts of interest.
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Critical Appraisal
Each article was examined for the level of evidence according to Melnyk’s system of
hierarchy (Research Guides, 2015). The articles included in this scholarly project’s literature
review included three cross sectional design studies, five randomized controlled trials, seven
non-randomized control trials, and five systematic reviews. The remaining articles varied from
levels of evidence I-IV, including quasi-experimental and randomized control trials. The quality
of each study is provided in Appendix A.
Systematic reviews. A systematic review was conducted in 2016 to evaluate the
utilization of mobile phones and tablets for self-care management in long term conditions. An
extensive web search was conducted via PubMed, Embase, EBSCO database, Cochrane library,
and the Joanna Briggs Institute Library (Whitehead & Seaton, 2016). The search consisted of
randomized control trials consisting of mobile-based technology that utilized mobile apps and
tablets for self-care management for T2DM, chronic lung disease, and cardiovascular disease
between 2005-2016 (Whitehead & Seaton, 2016). Nine studies were evaluated and reviewed for
this study. Six of those studies demonstrated statistical relevance and improvement in overall
clinical outcomes (Whitehead & Seaton, 2016). Three apps included interventions via the
utilization of mobile apps and demonstrated statistically significant improvement (Whitehead &
Seaton, 2016). Most interventions involved chronic care management of T2DM (5/9) studies
(Whitehead & Seaton, 2016). The duration of most interventions ranged from six weeks to one
year, with follow-up data from the various studies ranging from three months to one year
(Whitehead & Seaton, 2016). The number of study participants ranged from 48 to 288
individuals in the nine studies reviewed (Whitehead & Seaton, 2016).
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Findings from the systematic review supported the utilization of mobile apps to improve
symptom management and self-care management interventions (Whitehead & Seaton, 2016).
Utilization of mobile apps, such as iHealth, amongst those with chronic health issues displayed
more significant improvement in symptom management (Whitehead & Seaton, 2016).
Whitehead and Seaton (2016) encouraged further study evaluation to optimize the utilization of
mobile apps incorporated in chronic disease care management. Mobile app interventions provide
innovative ways to optimize the treatment of chronic care conditions (Whitehead & Seaton,
2016).
Randomized control trials. Recently, a randomized control trial by Garg, Shah, Aturk,
Benson, and Benergeon in 2017 supported the utilization of mobile-based technology in the
treatment of patients with diabetes. This randomized control trial consisted of N=100 compared
to a control group using self-monitoring blood glucose with Accu Check Nano synched with
iPhone. All subjects had similar clinic and phone visits for three months, with an extension of
three months for those utilizing the app. Participants within the study were required to have at
least eight visits during the designated study period (Garg et al., 2017). The goal of Garg et al.’s
research was to find out if utilization of the Accu Check Nano app would help decrease fear of
hypoglycemia, worry, and behavior sub-scores.
Garg et al. (2017) conducted a-six-month study utilizing the two groups with and without
the utilization of the Accu Check Nano synched app. At baseline, both groups had similar
glycosylated hemoglobin A1c values. However, at six months the intervention group had a
significant decrease in the hemoglobin A1c compared to the control group, who did not use the
Accu Check Nano app. (-.16 vs. -.51, p = 0.04) (Garg et al., 2017). Hypoglycemia fear and
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behavior scores of the control group were higher compared to the intervention group with no
increased risk of hypoglycemia (-1.4 ± 10.0 vs. -3.9 ± 12.5, p= 0.32) (Garg et al., 2017).
Limitations to Garg et al.’s (2017) study consisted of a short-term period (six months) in
one facility. In addition, the focus was geared toward only hypoglycemia risk without analyzing
other blood glucose variabilities (Garg et al., 2017). A strength of Garg et al.’s study was the
additional data produced that support the utilization of mobile app technology incorporated with
traditional diabetic management. Overall results from Garg et al.’s trial indicated that utilization
of the app with self-glucose monitoring improved diabetic management over a short period of
time.
In 2016, Goyal et al. conducted another randomized controlled trial that demonstrated the
ability of mobile app technology to improve diabetic self-management. The purpose of Goyal et
al.’s study was to see if utilization of a mobile app could facilitate and improve self-monitoring,
self-knowledge skills, and elicit positive behavior changes through effective self-management
skills of diabetes. The mobile app consisted of various functions geared toward improving better
self-care management of patients with diabetes. Functions included a daily step counter, dietary
menus, and incentive game with rewards. Each function within the mobile app supported ways
the patient could increase their self-improvement behaviors aimed towards better management of
the chronic disease. A strength of the mobile app was the structure it provided for participants.
Self-monitoring glucose reminders for N = 483 reduced their hemoglobin A1c on average
by 1.2%, compared to the control group utilizing traditional diabetic education methods of (0.4
to 0.6) (Goyal et al., 2016). In this study utilization of a game feature within the app improved
self-glucose measurements by an estimated 49.6% over a 12-week pilot. (Goyal et al., 2016). A
limitation of Goyal et al.’s (2016) study was the long-term sustainability of providing incentives
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to patients. Goyal et al.’s study reinforced that mobile apps serve as a wonderful complementary
tool with traditional diabetic education and improvement of self-care management techniques for
patients with T2DM.
Non-randomized control trials. In a non-randomized control trial in Singapore, Goh,
Tan, Chaun, and Uma (2015) developed an app called interactive diet and activity tracker
(iDAT) for use among patients with T2DM in various primary care settings. The objective was
to predict trajectories of app usage for disease management and to improve self-care
management of patients with T2DM (Goh et al., 2015). Goh et al. selected 84 participants who
had not previously had exposure to the iDAT app. Goh et al. divided participants into three
groups: minimal users (78.6%) with no previous iDAT usage; intermittent waning users (11.9%)
with occasional weekly usage during the first four weeks; and consistent users (9.5%) with
weekly usage. Goh et al. studied participants for app usage during an eight-week period. Most
participants were android users, accounting for approximately 70% (Goh et al., 2015).
Interestingly, most users reported strong utilization of their smartphone, with 87% reporting
using their smartphone more than five times per day (Goh et al., 2015).
After educational sessions on how to operate the iDAT app, users gave the app an
average rating score of 6 out of 9 on a 9-point scale (Goh et al., 2015). Participants who had
higher associated app usage reported increased levels of exercise. Results from Goh et al.’s
(2015) study supported mobile app technology as an excellent complementary tool for providers
to use to aid in the improvement of self-care management. Limitations to Goh et al.’s study
included mobile app data only available on a weekly basis. In addition, utilization of this app
only had a marginal usage rate of 3 to 4 out of every 10 users. Sample size for the study was
limited and could not effectively represent enough data for larger generalization. A strength of
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this study is the realistic feedback based on users’ mobile device app usage for similar studies in
the future (Goh et al., 2015). Goh et al. provided more realistic results of what could be seen
with self-motivation when compared with other popular mobile device apps.
Cross-sectional studies. Two cross-sectional design studies revealed a significant
correlation between self-knowledge of diabetes and improved hemoglobin A1c. Yang et al.,
(2016) conducted the first cross-sectional study in various regions of China (Western, Eastern,
and Mainland) with a total of 5,957 participants. Yang et al. utilized an implemented pre and
post survey to evaluate self-care improvement measures for T2DM post utilization over a 12month period. After the 12-month period Yang et al. evaluated participants via the implemented
post survey for diabetic knowledge regarding diet, exercise, blood glucose testing, foot care, and
medication testing. Yang et al. concluded that patients with good understanding of T2DM
improved to 72.1% from 46.8% prior to the implemented study.
Participants with good T2DM understanding had on average significantly lower fasting
blood glucose (FBG) and two-hour postprandial blood glucose and were more likely to use selfmonitoring blood glucose, exercise techniques, and medications than those who had a poorer
understanding (Yang et al., 2016). Patients with better understanding had better associated
outcomes (P < 0.001) (Yang et al., 2016). Strengths of Yang et al.’s study included a large
sample population, a variety of patient demographics, and extensive study length. All presented
data within the data had a P value less than P < 0.005 for significant relevance (Yang et al.,
2016). Weaknesses of Yang et al.’s study included the number of language dialects among
various regions and educational levels of sampled regions.
Synthesis
T2DM health disparities are common within various types of healthcare systems around
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the globe. Common barriers to effective T2DM management can be linked to patient behaviors,
access to healthcare, insufficient patient education, poor communication between providers and
patients, and inconsistent patient education. In a study conducted in 2017, Vencio et al. collected
data across various regions including Brazil, India, Japan, Spain, UK, and USA to identify
barriers to effective self-care management of T2DM. Interestingly, Vencio et al. reported that
diabetic education covered during traditional chronic care consultations across the various global
regions was the same. Diabetic education included healthy dietary intake, frequent exercise
regimen, and glycemic regulation regarding disease progression and management from most
providers (Vencio et al., 2017). Out of 1000 providers surveyed during this study, a common
reported issue amongst providers is that they wish they had more time at the beside with patients
to discuss effective self-care disease management techniques (Vencio et al., 2017). Importantly,
Vencio et al. provided substantial evidence that supports a disparity between what physicians
report they included in educational sessions versus what patients can remember during and after
those sessions for later recall. Vencio et al. noted education outside of traditional chronic care
appointments is vital and should be explored to optimize outcomes of patients with T2DM.
Utilization of mobile apps within clinical practice. There is a direct relationship
between the utilization of mobile apps and various positive effects on patients’ self-care
behaviors. Mobile-based app technology can be utilized in clinical practice to improve self-care
management of patients with T2DM. For instance, Schmocker, Zwahlen, and Denecke (2018)
implemented the usage of the diabetic app GlucoMan to help encourage self-care management of
patients with diabetes. Schmocker et al. encouraged patients over a six-month period to utilize
the app for blood glucose entry, diabetes information, and food tracking. The GlucoMan app
was found to improve patients’ ability to monitor their disease and empower better self-care
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management of diabetes for their health (Schmocker et al., 2018). Furthermore, the GlucoMan
app empowered patients to keep better track of their chronic illness.
Boyle, Grainger, Hall, and Krebs (2017) conducted research in New Zealand at an
outpatient clinic examined utilization of a diabetic apps in clinical practice to help improve selfcare management of patients with T2DM. Boyle et al. found that mobile app users were most
interested in mobile app functions such as an insulin dose calculator, diabetic diary, blood
glucose monitoring, and dietary carbohydrate. As evidenced by 200 implemented surveys,
patients were interested in learning how to utilize mobile apps to manage their chronic conditions
(Boyle et al., 2017).
Mobile app utilization in diabetic management. Studies were conducted to explore
various ways to optimize care for patients with T2DM. Ye, Khan, and Boren (2018) conducted a
study in China in which they reviewed various apps within the two biggest app platforms
available (iTunes and Google Play). Ye et al. interviewed six diabetic educators to examine the
efficiency of various app functionalities. Over 1050 mobile apps were reviewed for this study
(Ye et al., 2018). Mobile apps were reviewed applying the following criteria: functionality
within the clinical setting, user preferences, American Association of Diabetic Educators (AAED
7) criteria of healthy eating, physical activity, glucose monitoring, taking medication, problem
solving, healthy coping, and reducing risks (Ye et al., 2018). After inclusive criteria was applied
a remaining 310 mobile apps were selected for clinical usage in this study (Ye et al., 2018). Key
features of these apps consisted of empowering healthy eating, mediation adherence, daily
exercising, and disease monitoring (Ye et al., 2018). Exploration of the various apps found that
mobile technology served as an excellent complementary service to optimize patient outcomes
associated with T2DM. Recommendations for future diabetic apps encouraged the inclusion of
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more evidence-based guidelines to increase further self-care management of diabetes (Ye et al.,
2018).
Mobile-based technology has the power to reach all age groups, various patient
demographics, and has endless potential for patients with T2DM. Arnold, Solz, Quade, and
Kirch (2014) conducted a systematic review examining 656 mobile apps’ functionality to
determine if they could serve the needs of T2DM patients aged 50 years or older by expert app
usage. Arnold et al. noted a large variety of user capabilities within the various mobile apps. Of
user apps only 54.1% offered one simple function for end users, while 53% of the apps provided
a documentation function within the app (Arnold et al., 2014). The predominant language within
all examined apps was English (Arnold et al., 2014). Arnold et al. identified patients as the main
end user group for all the various apps. Interestingly, Arnold et al. identified no clear user
preference between free and paid apps.
Arnold et al. (2014) utilized a comprehension scale to grade various components within
the various apps. Scores generated from the comprehension scale represent app users’ ability to
navigate and understand overall app functions. Scores on the comprehension scale are ranked
from 0-5 with 0 as not able to use at all, 1 as extremely difficult to navigate and use app, 2 as
somewhat difficult to utilize the app, 3 as fair amount of difficulty utilizing the app, 4 as good
functionality within the app, and 5 as exceptional ease of app utilization. On average, most apps
scored a 4.0 out of 5.0 on the comprehension scale (Arnold et al., 2014). Arnold et al. reported
diabetic apps were effective interventional tools to promote self-care management tools for users
at or over the age of 50 years. Furthermore, Arnold et al. suggested that the target population is
well represented utilizing the mobile-based app technology. Arnold et al.’s results encourage
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providers to take a proactive stance in the incorporation of alternative complementary tools to
help improve self-care management associated with T2DM.
Utilization of mobile apps in underserved patient populations. Research reflects huge
disparities in healthcare for patients residing in rural communities. In order to effectively
address barriers for those at a disadvantage, healthcare providers must find ways to treat patients
outside of traditional diabetic educational methods. In 2015, Shadid, Mahar, Shaikh, and Shaikh
conducted a study in rural Pakistan consisting of 440 participants and a control group enrolled in
a randomized control trial study). The purpose of the study was to establish if mobile app
technology in a rural community for patients with T2DM would positively influence patient’s
hemoglobin A1c (Shadid et al., 2015). The mobile app sent reminders to patients every 15 days
during the 4-month study period (Shadid et al., 2015). Shadid et al. revealed participants who
utilized the mobile app had an increase from baseline in dietary planning from 17.3% to 43.6%
post mobile app intervention compared to the control group of 13.6% to 15.9%. Additionally,
participants showed a direct correlation with their hemoglobin A1c decrease of (RR= 2.71, 95%
CI=1.18-6.40) during the 4-month period. All participants compared to the control group had a
significant positive association with an improved hemoglobin A1c (Shadid et al., 2015). Results
within this rural community reinforced the value of managing patients T2DM outside of
traditional means who have lack of access to healthcare, limited transportation, and have mobile
technology available.
Mallow, Theeke, Barnes, Whetsel, and Mallow (2014) conducted an extensive integrated
review of mobile health supporting the utilization of mobile app technology to improve T2DM
care within rural community settings. A trigger for this integrated review was the critical need
for an effective intervention to help patients with T2DM in rural communities who face
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commonly associated barriers of rural healthcare (Mallow et al., 2014). Those barriers identified
include lack of access to healthcare, poor outcomes of patients within rural communities, and
lack of provider interventions (Mallow et al., 2014). Mallow et al.’s integrated review consisted
of evaluating all mobile technologies involved in the improvement of T2DM care. Mallow et al.
studied all relevant data within the inclusive criteria of the study from January to mid-August,
2013, for significant relevance surrounding mobile health technology in rural communities for
T2DM patients. Mallow et al. studied a total of 157 articles were reviewed, with 25 articles
meeting inclusive criteria. Results from the study supported the utilization of mobile app
technology to be effective at improving patients with T2DM outcomes, reducing costs to
patients, and an exceptional way to provide innovative treatment to communities with limited
resources (Mallow et al., 2014).
Conceptual Framework
The conceptual framework utilized for this scholarly project was the Iowa model (Titler
et al., 2001). This model is a commonly utilized framework for the implementation of evidencebased practice. The Iowa model utilizes seven triggers to effectively promote best evidencebased practice methods (Doody & Doody, 2012). The seven main components of the IOWA
model include: identify triggering issues, state the purpose, form a team, examine the evidence,
design the practice change, implement the practice change, evaluate and disseminate the results
(Doody & Doody, 2012). Permission was provided by the University of Iowa, Department of
Nursing to utilize the Iowa Model for this scholarly project (see Appendix B).
Identify triggering issues and state the purpose. No-show appointments are associated
with a higher risk of hospitalization for patient suffering from T2DM (Nuti et al., 2013). Often,
patients who “no-show” in primary care settings interrupt the ability of providers to provide
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consistent treatment (Nuti et al., 2013). Nuti et al. (2013) found that diabetic patients who did
not show to appointments displayed an increase of 60% risk for admission to the emergency
room (ER). The rural medical facility has a difficult time trying to keep diabetic education
appointments with patients due to high levels of no-show appointments.
Another barrier to effective management of diabetic patients within the organization is
effectively getting patients within the organization to keep diabetic education appointments after
traditional chronic care checkups. A trigger for the scholarly project set to explore solutions that
aid in resolving various barriers to effective self-care management education for patients in the
underserved patient population suffering from T2DM. This project site is committed to
providing health services, promoting health, reducing health risk factors, and increasing access to
the uninsured and underserved patient population (Rural Health Clinic, 2018). This scholarly
project aligned with the clinics mission by seeking to improve patient access in the underserved
patient population, decreasing risk factors with unmanaged T2DM, and promoting health
through improved self-care management techniques through utilization of the diabetes app.
Team development. Team development for this scholarly project began with
identification of key stakeholders for this scholarly project. This project team leader organized a
project team to effectively provide adequate resources to implement this scholarly project. This
team leader helped the team develop clear roles within the project, establish goals, establish
project team feedback, and develop a scholarly project timeline. The project team leader and
scholarly project chair worked collaboratively together to ensure the scholarly project utilized the
most evidenced-based practice during implementation of this scholarly project. The team leader
organized the team and oversaw all aspects of the project including implementation and
evaluation of this scholarly project. The scholarly project team members consisted of a scholarly
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project chair DNP, FNP-C, student DNP, FNP-C, DNP, FNP-BC, MSN, FNP-C, four LPNs, six
front desk ancillary staff within the selected organization, and a DNP FNP-C to help analyze
statistical results.
Examine the evidence. Evidence retrieval for this scholarly project was conducted by a
systematic literature review for best evidence-based practices surrounding the care of T2DM
utilizing mobile app technology. The lead team member reviewed all literature and discussed
evidence with all associated scholarly project team members. Studies consisted of quasi
experiment, random controlled trials, non-random controlled trials, systematic reviews, and
cross-sectional design studies. The team leader utilized the latest SPSS software for effective
clinical relevance to analyze the evidence after the imposed intervention.
The team leader examined each article for the level of evidence according to Melnyk’s
system of hierarchy (Research Guides, 2015). This scholarly project’s literature review
consisted of Levels I to III and Level 5 evidence. Level I evidence consisted of randomized
control trials and systematic reviews conducted within primary care settings utilizing mobile
apps to improve self-care management of patients with T2DM. Level II evidence articles
consisted of non-randomized control trials and cohort studies. Level III evidence articles
consisted of three quasi experimental design studies supporting mobile-based app technology for
the management of T2DM self-care management. Level V evidence consisted of observational
studies that support the utilization of mobile app usage within the primary care setting.
Design the practice change. The team leader implemented the standard utilization of
mobile app technology within the clinic. Mobile app technology utilization was based on strong
supporting evidence that consistently demonstrated positive outcomes with the incorporated
utilization of the Diabetes app for diabetic education for patients with T2DM. Clinical
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guidelines associated with the utilization of mobile-based app technology served the purpose to
assist providers and promote better clinical decision-making skills for self-care management of
T2DM. Evidence composed from the systematic literature review and similar studies helped
guide and develop evidence-based practices currently being provided to patients of similar
demographics and illnesses. Utilization of mobile-based apps within clinical practices has
produced substantial evidence of the positive impacts on patient outcomes. In a growing
technological era, mobile-based app technology can enhance the ability of providers to improve
self-care management of T2DM. Furthermore, the benefits of mobile apps and diabetes
management can break previous barriers associated with self-care management of T2DM within
the underserved patient populations. This scholarly project aimed to provide substantial
evidence that mobile app-based technology utilization incorporated into diabetic management
can produce reproducible results and can be effective within the target population.
Practice change implementation. One of the biggest challenges throughout healthcare
remains to be consistent effective implementation of the best evidence-based practices. The
scholarly project team leader demonstrated in order to effectively implement new standards
within an organization, there must be an understanding of organizational culture, a defined
process, a plan for effective implementation, and a provided effective evaluation (Cullen &
Adams, 2013). The scholarly project team leader utilized five steps to help with the
implementation of this evidence-based practice utilizing mobile-based app technology for
improved self-care management of T2DM. The five steps included: create awareness and
interest within the organization; build knowledge and commitment from all key stakeholders;
promote action and adoption via educational outreach and multidisciplinary team discussions;
pursue integration; and sustain use via evaluated results (Cullen & Adams, 2013).
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The scholarly project team leader started with the developmental process of the mobile
app with a software company named Appy Pie. The Diabetes app served as a “one stop shop”
education hub for patients with T2DM, available on both Android and iOS platforms. The app
consisted of several recommended ADA dietary changes, a built-in blood sugar log, healthy
exercise videos, a variety of meal plans, diabetic education in congruence with ADA
recommendations, various self-care management techniques, and a frequently-asked-questions
section.
This project team leader aimed to recruit 60 established rural health clinic patients who
met inclusive criteria for the scholarly project. Concluding the study, participants with the
highest mobile app utilization and lowest hemoglobin A1c decrease were entered in a raffle
drawing to win a 19-inch television. Prior to implementation all participants were provided a pre
and post diabetic questionnaire-based utilization of the mobile app and assessment of various
self-care management techniques. All participants were requested to download the mobile app
and utilize the Diabetes app daily during the three-month intervention period. During the threemonth period participants received two push notifications daily and received new downloadable
content weekly. All activity within the app was measured daily via google analytics for each
specific end user. The purpose for the change in practice was designed to break barriers
involving ineffective T2DM self-care management within the underserved patient population.
Evaluation and dissemination the results. Data-driven decision making and
incorporation of feedback from all essential stakeholders drove the vitality of this scholarly
project. Careful evaluation of p value, overall hemoglobin A1c response, and impact on selfcare management influenced the level of significance and future usage of the mobile app.
Personal feedback from participants allowed for further engagement needs for future app users,
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barriers to utilization, and strengths associated with the mobile app. Data was compared to prior
hemoglobin A1c levels for comparison purposes with traditional diabetic education and selflearning alone.
Results were distributed to participating scholarly project team members during the postimplementation and evaluation meeting. Furthermore, at this meeting the team discussed various
aspects of the conducted project and set the building blocks for the dissemination plan associated
with this scholarly project. Other members and staff associated with the organization were
provided a summary book, with the potential for an article or poster presentation with scholarly
project results.
Summary
The purpose of this literature review was to discover evidence-based practice strategies
for management of T2DM in underserved and uninsured populations. Evidence indicated mobile
apps improve symptom management through improved self-care management (Whitehead &
Seaton, 2016). In the current advanced technological era, utilization of mobile apps grants
healthcare providers another effective tool to encourage self-management of chronic illnesses.
The critical appraisal of data provided strong evidence for utilization of mobile apps within
clinical practice, mobile app utilization in diabetic management, and utilization of mobile apps in
underserved populations. DNPs have the knowledge and skills to work in collaboration with
software designers to help develop these apps for specific chronic illnesses. Literature supported
the need for this scholarly project, which was to decrease the hemoglobin A1c in patients with
T2DM by utilizing a mobile app to improve self-care management.
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SECTION THREE: METHODOLOGY
Design
The purpose of this scholarly project was to determine if the utilization of a Diabetes app
would decrease the hemoglobin A1c and improve the self-care management of patients
diagnosed with T2DM in the underserved patient population. The Diabetes app aimed to provide
the underserved patient population full-time access to improved self-care management
techniques and education to improve their hemoglobin A1c. This project served as an evidencebased performance project framed by the Iowa model for evidence-based performance. The
project design was based on extensive evidence in the literature and congruent with the steps of
the Iowa model. Triggering issues surrounding the care of T2DM patients in underserved
communities were identified and a team was developed to review the literature and address this
issue. The scholarly project team leader sought out to recruit 60 participants. However, only 30
participants were obtained during the three-month intervention window for daily utilization of
the Diabetes app. Prior to receiving the app, patients received education on its usage. The
project team leader utilized phone contact for this education, plus provided an in-app welcome
video tutorial. Pre- and post-Diabetic app questionnaires (demographics, self-care) were
distributed for baseline levels before and after the intervention. Additionally, participants
received push notifications daily at 8am and 6pm. Prior to implementation of the Diabetes app,
each participant had their hemoglobin A1c drawn pre- and post-app-utilization.
Measurable Outcomes
Goal 1: After completion of the three-month window with utilization of the Diabetes app,
patients would demonstrate a decrease in their Hgb A1c. This measurement would be evidenced
by comparing blood drawn pre- and post-Diabetic app utilization. Goal 2: After completion of

MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT

32

the three-month intervention of the Diabetes app, patients would demonstrate an increase in selfcare management behaviors associated with their T2DM. This measurement would be evidenced
by increased self-care management scores ranked by the Likert scores for all questions on the
pre- and post-survey Diabetic Self-Questionnaire (Appendix C).
Setting
This scholarly project was conducted in a small rural town in Virgina. Census results
revealed approximately 1600 people living in the selected study area (Bassett, Virginia [BV],
n.d.). Approximately 72.94% of these people were White, 24.14% African American, 0.07%
Asian American, and 1.79% other races (BV, n.d.). The average median income in Bassett was
$28,359. Of the households 22.6% have children under the age of 18. About 17.8% of the
population lived below the poverty line (BV, n.d.).
The health clinic is a community health center located in rural Virginia. It is a 10-room
medical facility, with over 20 employees ranging from certified medical assistants, licensed
practical nurses, translators, clinical supervisor, clinical director, registered nurses, five nurse
practitioners, two physicians, and is equipped with an in-house lab including EKG capabilities,
microscope, and performs various in clinic procedures. This family practice is dedicated to
providing comprehensive, primary health services to medically underserved residents of Henry
County regardless of their ability to pay. This health center receives grant funding program
under the 24 U.S.C 254b and is deemed a public health service employer (Rural Health Clinic,
2018). The clinical director of the organization provided a letter of support for the study taking
place at the site (see Appendix D).
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Population and Sample
Participants of this study consisted of those who met inclusive criteria. The scholarly
project team leader selected approximately 60 particpants within the inclusive criteria. The
targeted audience for this scholarly project was adults aged 19-70 years of age with a diagnosis
of T2DM for more than six months. Patients were required to have access to iOS or Android
device app stores with online capabilities. Patients were required to be established patients of the
clinic with a hemoglobin A1c greater than seven. In addition, participants were required to have
been referred to the diabetic educator within the last 12 months and English speaking only.
Exclusion criteria consisted of falling outside the designated age range, not having mobile device
access, not having smartphone capablities (app store), not being a rural clinic patient, not
speaking English, and having an hemoglobin A1c lower than seven or without a diabetic
educator referral within the last 12 months.
Ethical Considerations
The scholarly project team leader and project chair completed extensive research ethics
training to ensure protection of human subjects through the Collaborative Institutional Training
Initiative (CITI Training) and were awarded a certificate of successful completion (see Appendix
E). All aspects of the scholarly project were reviewed to ensure ethical standards were
maintained throughout the implementation of the scholarly project. The team leader reviewed all
aspects within the study to ensure the highest level of quality and integrity throughout the
duration of the project. The scholarly project was approved by the project chair and received
successful Liberty University Institutional Review Board (IRB) approval (see Appendix F). All
study participants were under a direct voluntarily basis, and at any time reserved the right to unenroll from the project.
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The scholarly project team leader distributed and retrieved in person the informed
consent forms during patients’ acute and chronic care visits. Each participant’s reading level
was assessed to ensure adequate reading literacy associated with participating in this scholarly
project. Scholarly project participants’ personal information remained confidential and
anonymous throughout utilization of the Diabetes app intervention period. All participants
received an informed consent and non-disclosure statement for participating in the scholarly
project (see Appendix G). According to the disclosure forms provided to patients at the time of
signing the informed consent, information was only discussed with direct scholarly project team
members. No personal information was shared with any other institutions or similar programs
without direct consent from participants. All patient information was carefully stored in an
Excel spreadsheet on an encrypted laptop. The scholarly project team leader reviewed all
aspects of the scholarly project to ensure the safety of all study participants prior to
implementation of the scholarly project. The scholarly project was not associated with any paid
firms and or institutions and did not receive any compensation for completion of this project.
Each study participant was assigned a coded number that was associated to them with generated
data for confidentiality purposes.
Data Collection
Data collection consisted of various tools utilized within this scholarly project.
Participants had their hemoglobin A1c drawn pre- and post-intervention during this scholarly
project. Other data collection tools associated with this scholarly project consisted of: Diabetes
app utilization (super user), diabetes self-care questionnaire with Likert ranking scoring
(Appendix C), and a demographics questionnaire (Appendix H). Study participants’ activity was
tracked via google analytics for detailed app utilization (number of logins, individualized screen
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time, app functions, and personalized data tracker). Each diabetic self-care questionnaire was
distributed in addition to instructions within the Diabetes app. Demographic questionnaires
required participants to provide age, race, annual household income, current diabetic
medications, and years living with diabetes. The project team leader collected all completed
questionnaires. Lab collection took place in a secured sterile environment, and samples were
collected by Labcorp employees within the inhouse lab during normal chronic care appointments
for enrolled participants. The project team leader collected all data utilizing the rural clinic Eclinical electronic health record system for each participant.
Tools
The implementation of this scholarly project consisted of several tools designed to
improve the self-care management of T2DM in the underserved patient population. Participants
were provided a 5-point Likert scale diabetes questionnaire and access for utilization of the
Diabetes app. The 5-point Likert scale diabetes self-care questionnaire was distributed pre- and
post-implementation of the scholarly project. Surveys evaluated each participant’s progression
and initial self-care management levels. The diabetes self-care questionnaire was a 10-question
survey designed to evaluate self-care management techniques of patients with T2DM.
Participants completed the questionnaire while in the office during their pre- and post-blood
work obtained during the project time period.
The Likert scale is a proficient scale of variability used in self-reported attitudes and
behaviors (Hartley & Maclean, 2006). Hartley & Maclean (2006) endorsed the Likert scale as
consistently providing better response rates than traditional yes and no, either/or, and open-ended
questions (Hartley & Maclean, 2006). Each question was scored 1 through 5 consisting of: 1
strongly disagree; 2 disagree; 3 neutral; 4 agree; and 5 strongly agree. Overall scores were
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totaled and placed into various categories based on raw scores. Raw scores of participants were
placed into the following categories utilizing a score bank sheet. Scoring of the questionnaire
was ranked per the following: 46-50 great; 41-45 good; 30-40 average; 20-29 poor; and 0-19 or
below bad. Appendix I presents the scale score ranking form. Scores were based on the amount
of self-care management techniques each study participant had at the time of completion before
and after Diabetes app usage. Literature supported patients with higher levels of self-care
management techniques have better chronic care disease management. This idea served as a
driving force behind this scholarly project to improve various self-care management techniques.
The following 10 items were utilized via the diabetic questionnaire utilizing the previous
corresponding Likert point scale to answer each question. (a) I check my blood sugar level at
home at least once a day. (b) I record my blood sugar level at least once per day. (c) I take my
diabetes medication at home as prescribed by my doctor or nurse practitioner. (d) I follow the
diabetic dietary recommendations given to me by my diabetic educator, physician, or nurse
practitioner. (e) I choose foods to eat that makes it easy to achieve good blood sugars levels. (f)
I plan my meals. (g) I use healthy diabetic recipes to prepare my meals. (h) I exercise 15 to 30
min minutes at least 3 times a week. (i) I keep all of the appointments recommended for my
diabetes treatment. (j) I use a diabetic app to help educate me on diabetes and health issues
associated with diabetes (see Appendix C). Hartley & Maclean (2014) reported utilization of the
Likert scale consistently produced moderate to strong internal consistency, test-retest reliability,
and concurrent validity. This questionnaire tool was developed for the scholarly project and
clinical setting and was not validated.
The Diabetes app was the second tool utilized for this scholarly project. The mobilebased app consisted of several self-care management functions for enrolled users. Users had
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access to seven main app widgets located on the Diabetes app home screen, plus an additional
information widget. App widget one consisted of a welcome video that provided patients an
overview of the scholarly project, project team leader introduction, goals during the three-month
intervention period, and a detailed screen by screen display of mobile app features and functions
shown directly by the project team leader (see Figure 1).

Figure 1. Welcome video and diabetes home screen.

App widget two consisted of pocket tools (daily blood sugar log, carb counter, and step
counter) within the mobile app. This widget provided patients the ability to track their blood
sugar daily and have easier access to stored information for future acute or chronic care visits for
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healthcare providers. This widget also allowed patients to review blood sugar trends, manage
carbohydrate intake for convenience food tracking, and step counter to monitor daily activity
levels (see Figure 2).

Figure 2. Pocket tools.

App widget three consisted of a structured to do list. Users were asked to complete as
many tasks on the daily to do list as possible during the three-month intervention window. The
following tasks were assigned every day during the three-month intervention window. Did you
check your blood sugar today? Did you take your diabetes medication today? Did I eat things
that help me achieve my blood sugar goals today? Did I have the opportunity to exercise today,
did I check my messages on the Diabetes app today, and did you give yourself credit for the
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small things today? (making better choices when eating, exercising, taking your medication etc.)
(see Figure 3).

Figure 3. To do list.

App widget four consisted of various educational YouTube videos (testimonials, diabetic
education, exercise videos, and various dietary meal plans and recipes). Healthy meal options
were directly in accordance with the American Diabetes Association (ADA). Dietary options
consisted of developed meal options catered to lower socioeconomic patient population. These
items were from stores such as Walmart, ALDI, and Family Dollar. Original meal plans covered
breakfast, lunch, and dinner. At the launch of the app, 21 meals were uploaded via various video
resources. New additional recipes and snacks were added each week consisting of snacks,
breakfast, lunch, and dinner options. All meal plans created and added by the project team
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leader were developed in collaboration with the diabetic educator and congruent with dietary
practice guidelines associated with the ADA (see Figure 4).

Figure 4. Videos.

App widget five, Did You Know, served as the main information hub associated with the
mobile app. This widget included information from the ADA on improving self-care
management techniques and frequent high-risk topics associated with T2DM. These self-care
management techniques consisted of basic T2DM information on frequently asked questions,
general medication information, exercise requirements, carbohydrate basics, medication
education, frequent problems with T2DM, a clearly defined carb counting formula for dietary
labeling, what to do on a sick day, foot care, eye care, hypoglycemia, hyperglycemia, injections,
checking blood glucose, heart disease facts, smoking impact, and weight loss (see Figure 5).
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Figure 5. Did you know.

App widget six consisted of a Contact Us function. Users were provided the direct
ability to contact the project team leader or project team chair with any concerns or questions via
phone call, text, or email. App widget seven consisted of a Find Info function. This widget
provided registered users a list of all included resources and documented references for content
provided within the mobile app (see Figure 6). The goal was to encourage participants to
explore the variety of resources available to help aid in effective management of those with
T2DM. Mobile app utilization for the management of self-care management techniques is
appropriate and provides benefits, as presented in the review of literature. For easy mobile
installation, each participant, at the time of consent, received mobile app instructions for the
Diabetes app (see Appendix J).
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Figure 6. Contact us & find info.

Intervention
Scholarly project development started with the identification of current barriers to
effective self-care management for patients with T2DM in the underserved patient population.
The scholarly project team leader developed a scholarly project team to help develop an
intervention to overcome barriers associated with ineffective self-care management techniques in
the underserved patient population. Goals associated with the Diabetes app aimed to improve
self-care management of patients with T2DM in the underserved patient population and decrease
overall hemoglobin A1c. A careful literature review was conducted to construct the top app
functions commonly associated with T2DM. Next, the scholarly project team leader worked
closely with Appy Pie software developers to develop a customizable app geared toward
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improving the self-care management of patients with T2DM based on most evidence-based
practices.
Approximately 60 participants (non-random) were screened who met inclusive criteria of
the scholarly project. Of those who met inclusive criteria, 30 were unavailable to participate in
the scholarly project or did not express interest within the required timeframe. Out of the
remaining 30 participants, nine participants dropped out the study before completion of the
study. Their various reasons included failing to turn in necessary requested questionnaires to
establish baseline data to obtain access to the mobile-based app, withdrawal after prescreening
conversation, and lack of consistent cellular service at the time. The remaining 21 participants
successfully completed all pre- and post-questionnaires, demographic forms, and utilization of
the Diabetes app during the required three-month intervention period.
The team leader of this scholarly project obtained in person consent from participants.
Nursing staff were educated about the study; however, nursing staff did not have much contact
with participants unless they came in for acute visits between their regular chronic care diabetic
visits. The team leader also placed at the nurse’s station a Diabetes mobile app instructional
handout for any participants who came in for acute visits and needed additional resources or
presented with questions. A pre- and post- 10-question questionnaire utilizing the Likert scale
was administered to all 21 participants in the scholarly project. The scholarly project was
implemented over a three-month period. Participants during the three-month intervention
window received two push notifications each day to their cellphones (8 am and 6 pm) consisting
of various messages pertaining to better self-care management techniques associated with
T2DM. These messages consisted of content like the following examples. (a) Hey, let’s get up
and get active today! (b) Did you check your blood sugar today? (c) Did you remember to take
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your diabetic medication today? (d) Check out these newly added healthy recipes inside the
diabetes app today to help with cravings and help keep blood sugars down. (d) Come check out
the diabetes app today for new content, and various health tips to aid in effective T2DM
management. (Did you know?…etc) (see Figure 7).

Figure 7. Notifications.

Following the scholarly project intervention period, participants returned to the clinic to
have their hemoglobin A1c redrawn and received the same 10-question Likert scale diabetes
questionnaire after Diabetes app utilization. Dissemination was conducted after implementation
and evaluation of the scholarly project results. After an extensive meeting, the clinic leadership
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team concluded there was a significant improvement in hemoglobin A1c and self-care
management techniques in patients who utilized the Diabetes app. Each participant received a
thank you letter for project participation. The scholarly project participant with the highest
correlating combined Diabetes app utilization, earliest project enrollment, and overall lowest
decreased hemoglobin A1c won the 19-inch LCD television. The winner of the 19-inch
television had an overall hemoglobin A1c decrease of 2.8%, enrolled in the project within 2
days, and had an increase in overall self-care management techniques by 34%!
Timeline
The scholarly project team leader spent 12 months on the project. This timeline included
the planning, pre-implementation, implementation, and evaluation periods of this scholarly
project. Please refer to Appendix K for a detailed table of the timeline of this scholarly project.
Feasibility Analysis
Various steps were taken by the scholarly project team leader to ensure the most costeffective and efficient measures were utilized while implementing the scholarly project.
Resources needed for this scholarly project included: various personnel within the clinic, various
resources and technology, and a strategic financial analysis of all mobile-based app technology.
Personnel at the clinic had a marginal role during this scholarly project. Personnel consisted of
ancillary staff and LPNs within the organization. Staff were only used to direct study patients
who may have come in for acute visits during the study period. Project resources were readily
available at the clinic for project participants during the project period and consisted of pre-made
Diabetes app booklets. The project team leader was available via email and phone for all study
participants with an anticipated 24-hours’ window response rates. Most staff participation
associated with this scholarly project were utilized in a capacity that did not require
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compensation from the project team leader. Any other staff within the clinic were compensated
accordingly in line with their hourly rates associated with their employment within the
organization.
Resources needed to draw pre- and post- hemoglobin A1c levels consisted of utilizing the
Labcorp within the selected facility, E-clinical health work network system to store all patient
information, and various handouts (consent, instructional guide, pre and post-survey
questionnaire, demographics questionnaire). All personnel associated with Labcorp are
contracted and paid by the clinic and obtained labs associated with participants during their
regularly scheduled chronic care visits. A 19-inch Vizio television was purchased for $45.00.
The Diabetic app start-up costs required a one-time fee of $10.00, with a monthly access fee of
$15.00 per month. Feasibility of the scholarly project was extremely reasonable compared to
incurred costs of patients who have persistent uncontrolled T2DM and associated hospital
admissions and other associated health complications. Overall resources and ancillary staff
involvement associated with the utilization of the Diabetes app were previously assigned job
functions within the rural clinic. Financial analysis revealed total incurred costs associated with
this scholarly project at $95.00. This is a marginal price compared to the billions of dollars spent
each year in our healthcare system.
Data Analysis
Data analysis consisted of utilizing SPSS software to analyze established measurable
outcomes for the scholarly project. SPSS software was utilized to identify correlations and
relationships between Diabetes app utilization and the direct impact on self-care management
techniques and hemoglobin A1c. Correlations were generated in the form of participants’ overall
hemoglobin average means, standard deviations, maximum, minimum, overall percentages,
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paired t-test, p-values, and Pearson correlation values to help evaluate and establish the level of
significance for the scholarly project. User activity was recorded during the three-month
intervention period and tracked utilizing google analytics. Google analytics provided both realtime data and overall time of users’ day to day mobile app usage. Generated data consisted of
providing response times to push notifications, widget usage, and the amount of screen time per
user utilizing the app. This information was generated and projected in reports via bar graphs,
actual minutes, and percentages for each individual number of clicks per widget for each end
user participating in the scholarly project. The pre-and post-survey information was analyzed
using SPSS software to determine differences in patient’s self-care management after the threemonth intervention. Data was formulated and integrated to identify trends and success for the
evidence-based practice scholarly project.
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SECTION FOUR: RESULTS
Out of 60 participants recruited 30 turned in all the required forms for participation in the
scholarly project. Of those, 21 participants successfully completed the demographics
questionnaire (Appendix H) and self-care management questionnaire (Appendix C) pre- and
post-Diabetes app utilization during the intervention period, and had required blood work drawn
for hemoglobin A1c evaluation before and after Diabetes app utilization. Nine participants
dropped out of the scholarly project, because they failed to complete pre- and post-study
bloodwork for hemoglobin A1c evaluation, voluntary withdrawal, or were unable to complete
the self-care management questionnaires required for baseline data collection before or after the
study period window.
Utilization of mobile-based technology for this scholarly project demonstrated significant
results in both improving the self-care management and decreasing hemoglobin A1c of study
participants in a rural underserved patient population. Demographics of the scholarly project
group reflected a yearly mean income of 17,986 dollars. N = 21 had a mean age of 43 years old,
(min = 19, max = 70). The mean age of participants since diabetic diagnosis was 11 years (min
= 1, max = 30). Participants in this scholarly project presented with the following education
levels: some college 14.2%, high school or diploma equivalent 42.9%, and did not finish high
school 42.9%. See Table 1 for characteristics and Table 2 for education and ethnicities of
participants.
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Table 1
Characteristics
Items

Means
45.19
11.28
18,399
1.95

SD
15.33
6.73
8318.69
1.02

Age
Years with Diabetes
Yearly Income
Number of Diabetic
Medications
Notes: SD= Standard Deviation, N=number of participants

Min/Max
19/70
1/30
1000/37,000
0/4

N
21
21
21
21

Table 2
Education and Ethnicity
Education

Frequency

Percent

N

Some College

3

14.3

21

High School or Diploma Equivalent

9

38.1

21

Did not complete high school

9

47.6

21

Graduate Degree

0

0

21

Caucasian

9

42.9

21

African American or Black

8

38.1

21

Hispanic or Latino

4

19

21

Other

0

0

21

Male

5

23.8

21

Female

16

76.2

21

Ethnicity

Sex

Notes: All applicants had the option to leave any information undisclosed
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Higher education of participants was associated with a lower incidence of uncontrolled
chronic disease management historically in various models aimed to improve the hemoglobin
A1c values. Participants reflected lower hemoglobin A1c control congruent with lower
educational levels associated with not completing high school versus high school diploma and
completing some college (see Table 3). In this project, N = 21 with gender represented as 28.2%
male and 76.2% female. Approximately 42.9% of participants did not complete high school,
42.9% completed high school or high school equivalent, and 14.2% of participants completed
some college. Data revealed lower educational levels were associated with less effective chronic
care disease management evidenced by less hemoglobin A1c management. Poor hemoglobin
A1c management is directly associated with increased health risk factors and increased mortality
associated with prolonged uncontrolled management of T2DM.

Table 3
Educational Level Group and Average Hemoglobin A1c
Items

Mean A1c

N

Some College

7.9

21

High School Diploma or
Equivalent
Did Not Complete High
School

8.24

21

9.3

21

Descriptive Statistics
Overall utilization of the Diabetes app during the three-month intervention window
demonstrated an improvement in overall hemoglobin A1c and self-care management techniques.
Futhermore, evidence demonstrated a direct improvement in self-care management techniques
based on average, good, and great overall ratings on initial self-care management techniques
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increased to 14.3% from 12.6% (+1.7%) after Diabetes app utilization. Participants who scored
poor and bad based on the Likert ranking score questionnaire had an initial mean of 30.9%
down to 9.52% (-21.38% ) for self-care management techniques in the previously mentioned
categories after Diabetes app utilization. Users also demonstrated an overall mean decrease of
2.34% hemoglobin A1c and overall decreased minimum and maximum hemoglobin A1c values
of (min = -1, max = -3.3) with app utilization.
Measurable Outcome 1.
Goal 1: After completion of the three-month Diabetes app intervention, patients would
demonstrate a decrease in their Hemoglobin A1c, evidenced by blood work drawn pre- and postapp utilization during the designated three-month intervention window. Participants presented a
significant hemoglobin A1c drop after utilization of the Diabetes app during the three-month
intervention window with an overall hemoglobin A1c mean decrease from prior to utilization of
the Diabetes app by 2.34% during the overall total three months’ evaluation (see Table 4).
Table 4
Pre- and Post-Diabetes App Utilization
Items

Mean
A1c%

SD

P-value

Min/Max

N

Pre-Diabetes App
Hemoglobin A1c

9.65

1.04

.004

7.20/11.90

21

Post-Diabetes App
Hemoglobin A1c

7.31

.600

.004

6.20/8.60

21

Notes: Mean A1c = Hemoglobin A1c, SD = Standard Deviation, Min/Max = Minimum
Hemoglobin A1c, Max Hemoglobin A1c, N = Sample Participant size

MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT

52

Measurable Outcome 2.
Goal 2: After completion of the three-month intervention of the diabetes app, patients
would demonstrate an increase in self-care management behaviors associated with their T2DM.
The accomplishment of this goal was demonstrated by an increase in the overall average Likert
ranking scores based on the Diabetes self-care questionnaire compared to the pre- and postDiabetes app utilization (see Table 5) for Likert ranking scores.
Table 5
Pre- Intervention Likert Ranking Scores with Correlating Hemoglobin A1c
Items

Mean
Hemoglobin
A1c

Number of
participants
in category

Percent of
select
categories

P-Values

Difference

N

46-50 Great

0

0

0

.015

0

21

41-45 Good

7.12

2

9.5

.012

0

21

30-40
Average

8.13

6

28.5

.016

0

21

20-29 Poor

9.15

7

33.3

.017

0

21

10.75

6

28.5

.018

0

21

0-19 Bad

Post Diabetes App- Intervention Likert Ranking Scores with Correlating Hemoglobin
A1c
46-50 Great

6.25

2

9.52

.006

+9.52%

21

41-45 Good

6.8

4

19.04

.004

+9.54%

21

30-40
Average

7.58

11

52.38

.004

+23.88%

21

20-29 Poor

8.45

3

14.28

.003

-19.02%

0-19 Bad

8.60

1

4.76

.002

-23.74%

Notes: N=Number of participants, Difference= Pre and Post Diabetes app utilization

21
21
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Utilization of the Diabetes app demonstrated a positive correlation between app usage
utilization and improved self-care management. Users in the poor and bad categories
demonstrated a significant overall improvement. All users had their activity tracked via google
analytics. Google analytics provided generated data associated with everyone’s app usage.
Usage was provided on each user’s daily app screen time, response time to push notifications,
most used app functions, and top widget selections. Participants with the highest amount of
screen time and Diabetes app interaction had a higher decrease in overall hemoglobin A1c during
the three-month intervention window (see Table 6).
Table 6
Google Analytics and Corresponding Average Hemoglobin A1c
Daily Usage

Percent of Users

Mean Hemoglobin
A1c decrease

N

3.5 or more hours per
week with at least 14
widget functions per
week

(8) 38.09%

1.1 %

21

2 to 3.4 hours per
week with at least 10
widget functions per
week

(6) 28.57%

.92 %

21

1 to 3.3 hours per
week with at least 5
widget functions per
week

(4) 19.04%

.68 %

21

0.5-3.1 hours per
week with at least 2
widget functions per
week

(3) 14.28%

.54%

21

Notes: N = Sample size of participants Items: All participants were rounded in the closest group
when placing into categories for weekly measurements.

MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT

54

SECTION FIVE: DISCUSSION
Implications for Practice
We have a rapidly evolving healthcare system with progressively more complex disease
processes than ever before. Healthcare must find innovative methods to optimize patient
outcomes with T2DM. Thus far, healthcare is losing the battle to effective T2DM management
at the exponential rate of billions of dollars each year. In a technological era, utilization of the
Diabetes app provided evidence that endorse further innovative ways to challenge barriers
associated with ineffective self-care management of patients with T2DM in the underserved
patient population. This scholarly project demonstrated mobile-based technology needs to be
incorporated into clinical practice guidelines associated with management of T2DM.
Updated clinical guidelines incorporating the utilization of mobile-based technology will
optimize the delivery of healthcare management for patients in the underserved patient
population. Mobile-based technology will serve to help patients achieve their target glycemic
goals and reduce mortality and morbidity. Additionally, incorporation of mobile-based
technology into clinical practice guidelines will directly improve access to healthcare for those in
underserved patient populations, offer creative ways to help engage patients to manage their
T2DM, and expand the ability of diabetic educators and providers to reach patients and increase
overall engagement.
Highest functionality associated with the Diabetes app gave healthcare providers clear
defined advantages over traditional diabetic educational methods and self-learning alone.
Streamlining real-time blood sugars promotes the ability for healthcare providers to make faster
recognition of patients’ glycemic control levels and aid in proper adjustments to help reduce
prolonged hypo or hyperglycemic events leading to uncontrolled hemoglobin A1c levels
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between three, six, and even 12-month intervals of chronic care visits. Videos within the
Diabetes app provided users additional educational resources for later recall outside of traditional
15 to 20-minute chronic care visits and 30 to 60-minute diabetic education class sessions. Video
media within the Diabetes app also provided users an innovate advantage for positive
reinforcement and quick access to recall critical self-care management techniques by personal
testimonials, exercise videos, and dietary meals to help facilitate better lifestyle choices.
Another great function of the Diabetes app was the use of self-care management icons
with a variety of information about T2DM and daily to-do list. Diabetes is one of the largest
healthcare disparities within the United States with rapidly increasing costs, changes with
medication administration, and continual rapid evolvement of oral glycemic agents and insulin
medications advancements each year. The heartbeat of effective T2DM is self-care management
techniques. If creative ways to improve self-care management techniques are not incorporated
into clinical guidelines, ineffective management of T2DM will always serve as a tremendous
challenge and burden within the healthcare system. This scholarly project had no conflict of
interest identified during the administration. Additionally, no biases were associated with the
implementation of this study.
Limitations
This scholarly project was conducted for the sole purpose of improving the self-care
management and decreasing the hemoglobin A1c of those with T2DM in the underserved patient
population. Project limitations associated with this scholarly project included a limited
timeframe to implement this study for the scholarly project team leader. Time limitations
directly influenced the available number of participants recruited for the scholarly project.
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Furthermore, the inability to attract Hispanic patients served as a limitation due to a language
barrier, and those with limited phone access or non-smartphone app capabilities.
Sustainability
Sustainability is one of the most challenging considerations when developing changes in
how future healthcare is delivered. The project site, as a rural low-income clinic, is designated
as a Federally Qualified Healthcare Center (FQHC). The clinic can challenge the longevity of
imposed practice guidelines with limitations on resources such as finances, staffing, and
challenging patient populations. Adherence of healthcare providers to newly introduced mobilebased technology is another important aspect to consider when implementing changes in clinical
practice guidelines. The rural health clinic must consider how to keep patients engaged with
newly introduced mobile-based technology. Resources should be considered and immediate,
short term, and long-term goals established. Additionally, the clinic must consider the
incorporation of the Diabetes app into current existing clinical practice guidelines for T2DM
management, the finances required to sustain mobile-based technology efforts, and the driving
force needed to continue developing the Diabetes app congruent with T2DM overall national
guideline changes. Long-term goals must include materials; staff for developing, implementing,
and continuing new guideline procedures; materials for participants; and staff and healthcare
provider education.
Healthcare staff adoption is another critical aspect in the success of this newly suggested
clinical guideline. Professional adherence is known to decrease as much as by 50% in relation to
personal bias, lack of understanding, and perceived quality of the guideline (Amet et al., 2015).
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Therefore, strong efforts must be taken to ensure all healthcare providers are provided adequate
education to effectively utilize the Diabetes app as a new clinical guideline for T2DM
management. Maintaining the immediate, short-term, and long-term goals rather than focusing
on short-term actions and short-term effect have been demonstrated from various research to
improve clinical guideline changes as much as 35% (Amet et al., 2015).
How can mobile-based technology like the Diabetes app become a daily part of
participants’ lives each day with T2DM? The most popular mobile-based technology around
offers user convenience and efficiency, provides a large spectrum of capabilities with reliability,
and is generally user friendly. Dependability is important for the Diabetes app in order to meet
several of the previously mentioned user preferences to sustain participant engagement with a
mobile-based app to aid with their chronic disease management.
Utilizing the diabetic educator and healthcare providers’ input from users is very
sustainable within the organization. The rural health clinic diabetic educator is a full-time staff
member with a great vantage point to identify needs and barriers that struggling patients with
T2DM face each day. Two forms of feedback will be generated through diabetic education
sessions and traditional chronic care visits conducted by healthcare providers. Longevity of this
scholarly project solely lies on the efforts and collaboration between the diabetic educator and
healthcare providers. Upkeep of the mobile-based technology is easy with advanced Software
developers like Appy Pie. The complexity and variations associated with the development of
mobile apps is simplified for input users to easily update and add new content. The same effort
required to upkeep and maintain standard guidelines for T2DM within the clinic can be applied
to updating the Diabetes app. However, these efforts serve to be a much more innovative way to
reach more patients effectively than traditional methods. Prioritizing methods with a constant
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evolving healthcare system should make efforts easier towards implementing methods that
encourage patients to become more a part of their chronic disease management.
Dissemination Plan
Evidence demonstrated by this scholarly project endorses the utilization of mobile-based
technology (Diabetes app), which effectively helped manage T2DM patients in the underserved
patient population. The scholarly project achieved two measurable outcomes over the threemonth intervention window after Diabetes app utilization. First, the Diabetes app demonstrated
a decrease in overall end users’ hemoglobin A1c, directly related to daily app usage. Second, the
Diabetes app directly improved the self-care management of T2DM in the underserved patient
population. Evidence supported a positive correlation with increased app usage and higher selfcare management scores after baseline and during the intervention window.
The scholarly project was developed for multiple applications in a variety of clinical and
non-clinical settings. The primary targeted audience for this scholarly project were those in the
underserved patient population. Beyond the target audience group the development behind the
Diabetes app served a much bigger purpose to help fight the seventh leading cause of death in
the United States. The Diabetes app was developed to be an innovative tool that could be used
by underserved patients, healthcare providers, healthcare centers, educators, and family and
friends. Partners associated with the Diabetes app consisted of a variety of sources in the
community.
The project study site receives federally funding from Health Resource Service
Administration (HRSA). HRSA has gone through extra lengths to improve the overall standards
of T2DM management across all FQHC receiving federally qualified funding as of 2018. Most
recent operational site visits require FQHC to establish a diabetic performance analysis goal over

MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT

59

a year, with quarterly progress reports aimed towards improving patients’ hemoglobin A1c levels
greater than nine throughout all health centers. The Diabetes app and utilization of mobile-based
technology will be shared as a part of various clinic initiatives to help obtain better controlled
hemoglobin A1c values. Information will be utilized and placed on the universal FQHC website
to serve as a resource for other FQHC to utilize within their organizations. Furthermore, the
scholarly project team leader started several initiatives to disseminate the results beyond
traditional scholarly project publication. The team leader has started progressive efforts towards
developing a manuscript to meet submission requirements to the Diabetes Care scholarly
publication. The project team leader has also taken efforts to produce the data and research on
various chronic care disease blogs, social media (Facebook), and ADA’s In It Together blog.
All submission research will be written to meet requirements of the submitting platform
requirements to match the reader audience. The Diabetes Care will follow requirements required
for scholarly publications, specifically providing a breakdown of the scholarly project in a
structured and formal methodical manner with associated medical terminology. However, social
media (Facebook) and ADA In It Together will be more informal presentations with the intent to
provide a more personable approach to utilization of the Diabetes app for those with T2DM.
Like the origin and development of this mobile app, the goal was to endorse a user-friendly
platform app to encourage patients to manage their T2DM. This scholarly project team leader
had several opportunities to evaluate the effectiveness of this dissemination plan through various
sources. The HRSA website is an area for FQHC to provide posted feedback on similar
protocols, policies, and new clinical guidelines. Facebook and the ADA blog will provide realtime responses from members to provide and engage users with new available resources. The
start of this dissemination plan relied on effective implementation within the clinic to
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demonstrate the Diabetes app as an effective tool compared to traditional diabetic educational
methods.
Conclusion
We have a rapidly evolving healthcare system with progressively more complex disease
processes than ever before. Healthcare must find innovative methods to optimize patient
outcomes with T2DM in the underserved patient population. Thus far, healthcare is losing the
battle to effective T2DM management at the exponential rate of billions of dollars each year. In
a technological era, utilization of the Diabetes app provided substantial evidence that endorsed
further innovative ways to challenge barriers associated with ineffective self-care management of
patients with T2DM in the underserved patient population.
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Appendices
Appendix A
Evidence Table

Article Reference.

Alexander, M.,
Christopher, B.,
Shatz, M., Schick,
T., Neauman, T.,
Kribbs, A., ... Stefan,
B. (2016). A mobile
application improves
therapy-adherence
rates in elderly
patients undergoing
rehabilitation: A
crossover design
study comparing
documentation via
iPad with paperbased control.
Medicine, 95(36),
4446.
doi:10.1097/MD.000
0000000004446

Study
Purpose

This study
focused on
whether
mobile
application
could support
therapy
management
for patients
with chronic
conditions and
improve
therapy
adherence
(Alexander et
al., 2016).

Sample
(Characterist
ics of the
Sample:
Demographic
s, etc.)
N= 24 patient
study.

Methods

Study Results

Nonrandomization
trial.

The mobile
app for
medication
adherence
increased
objectively
and
subjectively
medicine
adherence
(Alexander et
al., 2016).

Level of
Evidence
(Use Melnyk
Framework)
Level III:
Quasi
Experimental

Study
Limitations

Medication
intake needed
to be
confirmed via
iPad.
Adherence
was reported
from patients
does not
confirm
adhering to
medication
regimen, and
short length of
study
(Alexander et
al., 2016).

Would Use as
Evidence to
Support a
Change? (Yes
or No)
Provide
Rationale.
Yes, this data
is supportive
of mobile
technology
increasing
medication
adherence.
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Arnold, M., Solz, D.,
Quade, M., & Kirch, W.
(2014). Mobile
applications for diabetics:
A systematic review and
expert-based usability
evaluation considering
the special requirements
of diabetes patients age
50 years or older. JMIR
Publications, 16(4), 104.
doi:10.2196/jmir.2968

Examined
whether the
available
applications serve
the special needs
of diabetes
patients aged 50
or older by
performing an
expert-based
usability
evaluation
(Arnold et al.,
2014).

Boyle, L., Grainger, R.,
Hall, R., & Krebs, J.
(2017). Use of and beliefs
about mobile phone apps
for diabetes selfmanagement: Surveys of
people in a hospital
diabetes clinic and
diabetes health
professionals in New
Zealand. JMIR mHealth
uHealth, 5(6), 85.
doi:10.2196/mhealth.726
3

The purpose of
this study was to
see if the usage of
apps in New
Zealand for DM
self-management
and evaluate
desirable features
of apps. Also, to
evaluate
providers
recommending
app usage (Boyle,
Grainger, Hall, &
Krebs, 2017)
To design,
develop, and pilot
an mHealth
intervention for
the management
of type
1 diabetes in
adolescents

Cafazzo, J., Cassleman, M.,
Hamming, N., Katzman,
D., & Palmert, M. (2012).
Design of an mHealth app
for the self-management
of adolescent type 1
diabetes: A pilot study.

N=656 free apps
N= 379 paid apps

12 months
(N=539) assessed
current app use
and desirable
features. A
second survey of
HPs attending a
diabetes
conference
(n=286) assessed
their confidence
with app
recommendations
and perceived
usefulness.
A pilot group of
20 adolescents
aged 12-16 years,
with a glycated
hemoglobin
(HbA(1c)) of
between 8% and

Performed app
review based on
the information
given in the
Google Play
Store, the Apple
App Store, and
the apps
themselves. In
addition, we
carried out an
expert-based
usability
evaluation based
on a
representative
10% sample of
diabetes apps
(Arnold et al.,
2014).
This crosssectional study
observational
study

Non-randomized
control trial
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With patient and
physician input
during the
development of
mobile apps for
T2DM. Mobile
apps can be a
useful tool to
assist in the
management of
T2DM.

Level I:
Systematic
Review

The systematic
review was only
on iOS and
android
platforms.
Limiting the
general number
of available apps
to research
(Blackberry,
google, Windows
phone etc.)
(Arnold et al.,
2014).

The most favored
app functions
were recorded
blood glucose. It
recommends
further
developing
assessment
process to give
confidence in the
quality and safety
of diabetes apps
(Boyle et al.,
2017).

Level V:
Observational
Study

A large patient
size was utilized,
risk of over
presentation by
poor literate
responders. Lack
of access to keep
up with app
consistently.

This mHealth
diabetes app with
the use of
gamification
incentives
showed an
improvement in
the frequency of

Level III: Quasi
Experimental

Limitations of
this study are
based on each
user’s ability to
effectively
navigate the
mobile app.
Limited access to

Yes. Patients and
physicians alike
should be
involved in the
app development
process to a
greater extent.
User performance
of individuals
aged 50 or higher
was moderate to
good (Arnold et
al., 2014).

A large patient
size was utilized,
risk of over
presentation by
poor literate
responders. Lack
of access to keep
up with app
consistently.

Yes, this study
demonstrates that
that the utilization
of a mobile app
improves the
overall health
outcome of
patients with DM.
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JMIR, 14(3), 70.
doi:10.8898/10-93284

(Cafazzo,
Cassleman,
Hamming,
Katzman, &
Palmert, 2012).

10% was
sampled.

Chavez, S., Fedele, D., Guo,
Y., Bernier, A., Smith,
M., Warnick, J., &
Modave, F. (2017).
Mobile apps for the
management of diabetes.
Diabetes Care, 40(10),
145-146.
doi:10.2337/dc17-0853

The purpose of
this study was to
assess whether
popular apps for
diabetes
management
enough quality to
complement
clinical care
(Chavez et al.,
2017).

A total of 120
apps. Before
download, we
eliminated
duplicate apps (n
= 11), apps in
Spanish (n = 3),
prank apps (n =
2), and a pet
diabetes app (n =
1). 89 remained
after for usage
(Chavez et al.,
2017).

A meta-analysis
(systematic
review)

Desveaux, L., Shaw, J.,
Saragosa, M., Soobiah,
C., Marani, H., Hensel, J.,
. . . Jeffs, L. (2018). A
mobile app to improve
self-management of
individuals with type 2
diabetes: Qualitative
realist evaluation. Journal
of Medical Internet
Research, 20(3), 81.
doi:10.2196/jmir.8712

The purpose of
this study was
aimed to evaluate
a web-based
solution for
improving selfmanagement of
diabetes type two
(Desveaux et al.,
2018).

N=26 interviews
(14 baseline and
12 follow-up)
16 participants
had T2DM

Randomized wait
control group

69
blood glucose
monitoring in
adolescents with
type 1 diabetes
(Cafazzo et al.,
2012).
This study
suggested that
additional work is
needed to assess
the clinical
significance of
apps for diabetes
self-management,
and that app
developers should
work closely with
health care
providers and
patients when
building such m
Health tools
(Chavez et al.,
2017).
Self-efficacy,
competing
priorities,
previous
behavior, and
beliefs about web
solutions
influence
utilization of web
activity. Web
solutions could
tailor to improve
diabetes
management with
suboptimal
management
(Desveaux et al.,
2018).

smartphone, and
small group
sample (Cafazzo
et al., 2012).

Level I:
Systematic
Review

This study only
included free
apps. In addition,
the study did not
account for
behavior or
health outcomes

Yes, this study
provided a view
at a great
standardized tool
to support the
utilization of
mobile app
technology
incorporated with
diabetes
management.

Level II:
Experimental
Design

Participation in
this study was
voluntary, which
could result in
selection bias.
Limited ability of
transferring data
applicable to
larger population
with small study
size (Desveaux et
al., 2018).

Yes, this study
utilizes enough
data to support
the potential for
mobile app
influence on DM
management.
Sample size
significant
enough to provide
insight for future
study.
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Garg, S., Shah, V., Aturk,
H., Benson, C., &
Benergeon, J. (2017).
Role of mobile
technology to improve
diabetes care in adults
with type 1 diabetes: The
remote-tid study iBGStar
in type 1 diabetes
management. Diabetes
Therapy, 8(4), 811-819.
doi:10.1007/s13300-0170272-5

To further
evaluate the
effectiveness of
mobile
technology in
relation to patient
related outcomes
(Garg, Shah,
Aturk, Benson, &
Benergeon, 2017)

N=100
N=50 iBGstar
app
N= control group

Randomized trial

The mobile app
ibgstar app had
the same amount
of hemoglobin
A1c decrease at
three months.
However, at 6
months the
iBGstar had an
increased
decrease in
hemoglobin A1c
(Garg et al.,
2017).

Level II:
Experimental
design

Short term only
limited to six
months. Only
conducted within
one facility and
could not be used
for generalization
of results (Garg et
al., 2017).

Yes, this data was
strongly
supported.

Goh, G., Tan, N., Chaun,
M., & Uma, B. (2015).
Short-term trajectories of
use of a caloricmonitoring mobile phone
app among patients with
type 2 diabetes mellitus in
a primary care setting.
JMIR Publications, 17(2),
33. doi:10.2196/jmir.3938

The objective of
this study is to
identify and
describe shortterm (8-week)
trajectories of use
of the iDAT app
among patients
with type 2
diabetes mellitus
in a primary care
setting in
Singapore and
identify patient
characteristics
associated with
each trajectory
(Goh, Tan,
Chaun, & Uma,
2015).
The present
study asked if
the addition of a
tailored mobile
coaching (TMC)
system to current
primary care for
diabetes
management
resulted in better

A total of 84
patients with type
2 diabetes
mellitus from a
public primary
care clinic in
Singapore who
had not
previously used
the iDAT app
were enrolled

Non-randomized
control study

This study
provides insight
into the nature
and extent of
usage of a
caloricmonitoring app
among patients
with type 2
diabetes and
managed in
primary care.
This study
provided a vital
framework for
future mobile app
management of
DM (Goh et al.,
2015).

Level III: Quasi
Experimental

Smaller sample,
with limited
length of study
time.
Results limited to
one facility,
reduces
generalization to
the general
population.

Yes, this study
provides sound
support for the
utilization of
mobile app
technology in the
management of
patients
diagnosed with
DM. It offers a
great tool to help
patients with selfcare management.

Maintenance (IM) group
(n = 74) and
ControlIntervention (CI) group
(n = 74).

Randomized,
controlled, openlabel trial,
conducted from
October 2014 to
December 2015
in Kangbuk
Samsung
Hospital, Seoul,
Korea, and

In this study, we
evaluated the
effect of TMC in
diabetes care
when added to
the usual current
diabetes
management and
investigated
whether this

Level II:
Experimental
design

Medication
compliance could
not be confirmed.
User
comprehension of
the TMC system
was not
considered.

Yes, strong data
was presented in
this wellcontrolled study
for better
glycemic control
via mobile
technology.

Goyal, S., Morita, P., Lewis,
G., Yu, C., Seto, E., &
Cafazzo, J. (2016). The
systematic design of a
behavioral mobile health
application for the selfmanagement of type 2
diabetes. Canadian
Journal of Diabetes,
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40(1), 95-104.
doi:10.1016/j.jcjd.2015.0
6.007

glycemic control
and other
diabetes-related
outcomes in
adult patients
with type 2
diabetes
compared to
standard diabetes
management
(Goyal et al.,
2016).

Holmen, H. (2017). Mobile
health for diabetes selfmanagement
(Unpublished doctoral
dissertation). University
of Oslo, Norway.
Retrieved from
https://www.duo.uio.no/b
itstream/handle/10852/59
412/PhD-HolmenDUO.pdf?sequence=1

The present
study asked if
the addition of a
tailored mobile
coaching (TMC)
system to current
primary care for
diabetes
management
resulted in better
glycemic control
and other
diabetes-related
outcomes in
adult patients
with type 2
diabetes
compared to
standard diabetes
management
(Holmen, 2017).

consisted of 2
phases

Maintenance (IM) group
(n = 74) and
ControlIntervention (CI) group
(n = 74).

Randomized,
controlled, openlabel trial,
conducted from
October 2014 to
December 2015
in Kangbuk
Samsung
Hospital, Seoul,
Korea, and
consisted of 2
phases (Holmen,
2017).
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effect was
repeatable in
other participants
and maintained
without active
intervention.
After 6 months,
HbA1c levels
were
significantly
decreased by
0.6%. This
improvement
was reproduced
in the other
group of
participants and
remained after
removal of
individualized
message
feedback (Goyal
et al., 2016).
In this study, we
evaluated the
effect of TMC in
diabetes care
when added to
the usual current
diabetes
management and
investigated
whether this
effect was
repeatable in
other participants
and maintained
without active
intervention.
After 6 months,
HbA1c levels
were
significantly
decreased by
0.6%. This

Level II:
Experimental
Design

Medication
compliance could
not be confirmed.
User
comprehension of
the TMC system
was not
considered.

Yes, strong data
was presented in
this wellcontrolled study
for better
glycemic control
via mobile
technology.
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Irvine, B., Russell, H.,
Manocchia, M., Mino, D.,
Glassen, T. C., Morgan,
R., . . . Ary, D. V. (2015).
Mobile-web app to selfmanage low back pain:
Randomized controlled
trial. JMIR, 17(1), 1-10.
doi:10.2196/jmir.3130

This study
evaluated the
efficacy of
a mobile-Web
intervention
called "FitBack"
to help users
implement selftailored strategies
to manage and
prevent NLBP
occurrence
(Irvine et al.,
2015).

597 adults were
recruited,
screened,
consented, and
assessed online at
baseline, at 2
months (T2), and
at 4 months (T3).

NRCT

Jo, I., Yoo, S., Lee, D.,
Park, C., & Kim, E.
(2017). Diabetes
management via a mobile
application: A case
report. Clinical Nutrition
Research, 6(1), 61-67.
doi:10.7762/cnr.2017.6.1.
61

The Healthy-note
app was designed
to enable patients
to record and
monitor selfmanagement
activities
(SMBG, diet,
exercise, and
medication),
providing the
patient with a
self-learning
function (Jo,
Yoo, Lee, Park,
& Kim, 2017).

Two case study
patients utilizing
healthy note app.

Cohort Study

72
improvement
was reproduced
in the other
group of
participants and
remained after
removal of
individualized
message
feedback
(Holmen, 2017).
This research
demonstrated that
a theoretically
based standalone mobileWeb intervention
that tailors
content to users
preferences and
interests can be
an effective tool
in selfmanagement
of low back pain
(Irvine et al.,
2015)
Mixed results.
Patient one who
was actively
engaged in
mobile app had a
decrease in
Hemoglobin A1c
(Jo et al., 2017).

Level III:
Quasi
Experimental

User knowledge
of technology
(web application
and app).

Yes, data
supported from
this study
indicates several
indications for
various chronic
illness.

Level IV
evidence: Cohort
design

Small sample
population
Hard to
generalize results
with small
sample.

No, limited data
supportive to
efficiently support
the data provided
by the two
participants.
However, this
does spark the
need for further
research if results
can be
demonstrated
again.
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Lithgow, K., Edwards, A.,
& Rabi, D. (2017).
Smartphone app Use for
diabetes management:
Evaluating patient
perspectives. JMIR
Diabetes, 2(1), 2.
doi:10.2196/diabetes.664
3

The purpose of
the study was to
gain insight into
patient
experiences
related to the
usage of
smartphone usage
for diabetes
management
(Lithgow,
Edwards, & Rabi,
2017).
The purpose of
this study
mHealth mobile
technology be
used effectively
as an intervention
improve chronic
disease
management
(Mallow, Theeke,
Barnes, Whetsel,
& Mallow, 2014).

N=12
questionnaire
survey of app
usage diagnosed
with T1DM. 7
men and 5
women.

Non-randomized,
purposive
sampling
strategy.

N= 23 articles
that meet
inclusive criteria.

Systematic
Review

Schmocker, K. S., Zwahlen,
F. S., & Denecke, K.
(2018). Mobile app for
simplifying life with
diabetes: Technical
description and usability
study of GlucoMan. JMIR
Publications, 3(1), e6.
doi:10.2196/diabetes.816
0

Develop a mobile
app that provides
secure collection
data and stores
vital diabetic
information such
as (blood sugars,
hemoglobin A1c)
with provider
access to patient
information.

N- 6 app users

Schreier, G., Eckman, H.,
Hayn, D., Kriener, K.,
Kastner, P., & Lovell, N.

The purpose of
this study was to
see if the mobile

N=403 patients
enrolled in the
program

Mallow, J. A., Theeke, L.
A., Barnes, E. R.,
Whetsel, T., & Mallow,
B. K. (2014). Using
mHealth tools to improve
rural diabetes care guided
by the chronic care
model. Online Journal
Rural Health Care
Nursing, 14(1), 43-65.
doi:10.14574/ojrnhc.v14i
1.27

256 articles
screened

Non-randomized
control trail

2= T2DM
4= Non-T2DM

Non-randomized
control trial
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Participants
displayed the
interest in having
more apps with
more features to
help manage their
diabetes. Current
app technology
must be geared
towards catering
to patient’s needs
(Lithgow et al.,
2017).
Mobile app
utilization in the
underserved
patient population
can improve
patient outcomes
drastically. A
recommendation
to incorporate
further mobile
technology in the
healthcare model
is recommended
(Mallow et al.,
2014).
Data collection
for patients with
T2DM can be
supported via the
utilization of
mobile apps.
These mobile
apps provide
patients the
ability to monitor
relevant
parameters set by
their providers.
The results
obtained in this
study of patients

Level III: Quasi
experimental

Lack of
generality and
cannot be applied
to larger
population
(Lithgow et al.,
2017).

Yes, this study
shows patients
want more
technological
apps geared
towards
supporting selfmanagement.

Level I:
Systematic
Review

Limitations of
this study consist
of studying
mobile apps with
only providers
who endorse
outside traditional
care. It was hard
to make
generalization for
effectiveness if
the provider did
not support app
utilization.

Yes, this study
supports the
mobile
technology as the
future in
healthcare. The
results endorse
cost effectiveness,
improving
healthcare access,
and overall
improving patient
outcomes.

Level III: Quasi
Experiment

Limitations of
this study consist
of limited study
participants.
Hard to apply
study results for
larger population.

Yes, despite
limitations of this
study, still
supported that
data can be safely
streamed securely
to providers via
mobile apps.
Providing a great
tool for providers
and convenience
for app users.

Level III: Quasi
Experimental

Limitations of
this study were
based on the user

Yes, cautiously.
This study
supported both
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(2013). Web versus app –
compliance of patients in
a telehealth diabetes
management
programming two
different technologies.
Journal of Telemedicine
& Telecare, 18(8), 476480.
doi:10.1258/jtt.2012.GTH
112

Shadid, A., Mahar, S. A.,
Shaikh, S., & Shaikh, Z.
U. (2015). Mobile phone
intervention to improve
diabetes care in rural
areas of Pakistan: A
randomized controlled
trial. Journal College
Physician Pakistan,
25(3), 166-171.
doi:03.2015/JCPSP.1661
71

app could support
physicians
achieve
sustainable
lifestyle
modifications,
tailor therapy to
individual needs,
increased therapy
adherence and
safety (Schreier
et al., 2013).

N=291 app
controlled
N=109 Web
controlled

To determine the
effect of mobile
phone
intervention on
HbA1c in type-2
Diabetes Mellitus
(DM) patients
living in rural
areas of Pakistan
(Shadid, Mahar,
Shaikh, &
Shaikh., 2015).

N=400
N=200 controlled
N=200 noncontrolled group

Randomized
Control Trial
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in a telehealth
diabetes
management
program revealed
a significantly
higher
compliance rate
for patients using
a mobile phone
and NFC-based
application user
interface to
acquire and
transmit their
health data than
for patients
predominantly
submitting data
via a webbrowser (Schreier
et al., 2013).
Patients
in intervention
group showed
improvement (p <
0.001) in
following diet
plan from 17.3%
at baseline to
43.6% at endline,
however, the
control group
showed
insignificant
increase
(p=0.522) from
13.6% at baseline
to 15.9% at
endline.
Intervention
group (RR =
2.71, 95% CI =
1.18 - 6.40)
showed
significant

Level 3:
Quasi
Experimental

preference, and
overall resources
for each
participant.

web and mobile
apps improving
self-care
management of
diabetes. Data
was not
supportive of app
usage alone.

Patients were
followed for 4
months. It is very
difficult to
change certain
parameters like
BMI in such short
time duration.
Only patients
presenting to one
hospital in
Karachi and
patients who
were from two
rural regions of
Pakistan were
studied due to
defined
catchment area of
the hospital
(Shadid et al.,
2015).

Yes, despite the
current limitations
associated with
the study. There
was a significant
amount of
improvement with
the utilization of
mobile app
intervention.
Enough to
endorse further
studies that utilize
mobile apps as
complementary
treatments for
T2DM.
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Shah, V. N., & Garg, S. K.
(2015). Managing
diabetes in the digital age.
Clinical Diabetes and
Endocrinology, 1(16), 2036. doi:10.1186/s40842015-0016-2

A systematic
review was
conducted to
review new
digital
technologies in
diabetes self-care
management and
address potential
challenges (Shah
& Garg, 2015).

N=22 mobile
apps

Whitehead, L., & Seaton, P.
(2016). The effectiveness
of self-management
mobile phone and tablet
apps in long-term
condition management: A
systematic review. JMIR,
18(5), 97-108.
doi:10.2196/jmir.4883

A systematic was
conducted review
and assess the
effectiveness
of mobile phone
and tablet apps in
self-management
of key symptoms
of long-term
conditions
(Whitehead &
Seaton, 2016)

Yang, S., Kong, W., Hsue,
C., Fish, A. F., Chen, Y.,
Guo, X., ... Anderson, R.
(2016). Knowledge of
A1c predicts diabetes
self-management and A1c
level among Chinese
patients with type 2
diabetes. PLoS One,
11(3).

The study was
designed to
assess the
knowledge of
A1c and its
relationships with
diabetes selfmanagement and
A1c level among
Chinese patients

9 papers we
reviewed, 6 of the
interventions
demonstrated a
statistically
significant
improvement in
the primary
measure of
clinical outcome.
Participants
ranged from 48 to
288 per year
(Whitehead &
Seaton, 2016).
A study sample
of 5957 patients
was utilized.
3040, 1247, and
1670 were from
Eastern, Central,
and Western
China (Yang et
al., 2016).

Systematic
Review

All apps endorse
selfcare
management
techniques for
patients

75
positive
association with
normalization of
HbA1c levels
(Shadid et al.,
2015)
This study
supports that
overcoming
barriers
associated with
mobile
technology for
self-care
improvement of
T2DM is
promising (Shah
& Garg, 2015).

Level I:
Systematic
Review

Limitations of
this study consist
of large
healthcare
systems that can
not overcome
barriers with
incorporating
mobile
technology into
healthcare (Shah
& Garg, 2015).

Yes, this study
effectively
addressing
various barriers to
incorporating
mobile
technology into
diabetic
management in
the digital age.

Systematic
Review

The evidence
indicates the
potential of apps
in improving
symptom
management
through selfmanagement
interventions
(Whitehead &
Seaton, 2016).

Level I:
Systematic
Review

Two selected
apps only during
the selected time
frame. More
rigorous research
needed on larger
scale to improve
research results.

Yes, this study
supports various
trials that have
improved patient
outcomes with the
Incorporation of
mobile apps.

Cross-Sectional
study

The results also
show that there
was a correlation
between
understanding of
A1c, diabetes
self-management
behavior and
glycemic control.
This implies that

Level IV: Crosssectional study

Limited factor
assessment of
hemoglobin A1c
control.
Limited
questionnaire

Yes, provides a
large sample with
the correlation
between increased
education and
improved A1c.

MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT
doi:10.1371/journal.pone.
0150753

with type 2
diabetes (Yang et
al., 2016).

76
a good
understanding of
A1c can improve
clinical
outcomes, such as
FBG, 2hPPG, and
A1c. Those with
better
understanding
understood their
A1c performed
better selfmanagement
behavior (Yang et
al., 2016).

Clinical Question: In underserved patients with T2DM, does utilization of a Diabetes App, compared to previous self-care
management and clinic education, lower the Hemoglobin A1c over a three-month period?
*Note: Melnyk’s Level of Evidence (LOE) Pyramid is required for appraising the level of evidence.
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Appendix B
Permission to Use and/or Reproduce The Iowa Model (1998)
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtrics-survey.com>
Mon 11/19/2018, 3:33 AM
To:
Smith, Fred <fsmith23@liberty.edu>
You have permission, as requested today, to review and/or reproduce The Iowa Model of Evidence-Based Practice to Promote Quality
Care (Revised 1998). Click the link below to open.

The Iowa Model of Evidence-Based Practice to Promote Quality Care (Revised 1998)

Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted for placing on the internet.

Citation: Titler, M. G., Kleiber, C., Steelman, V. J., Rakel, B.A., Budreau, G., Everett, L. Q., ...Goode, C. J. (2001). The Iowa model
of evidence-based practice to promote quality care. Critical Care Nursing Clinics of North America, 13(4), 497-509.
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In written material, please add the following statement:
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 1998. For permission to use or
reproduce, please contact the University of Iowa Hospitals and Clinics at 319-384-9098 .

Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions.
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Appendix C
Diabetic Self-Questionnaire
Please circle the following questions below according to your current lifestyle
1= strongly disagree
2= disagree
3= neutral (neither agree or disagree)
4= agree
5= strongly agree

1. I check my blood sugar level at home at least once a day
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
2. I record my blood sugar level at least once daily.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
3. I take my diabetes medication at home as prescribed by my doctor or nurse practitioner.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
4. I follow the diabetic dietary recommendations given to me by my diabetic educator, doctor, or nurse practitioner.
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1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
5. I choose foods to eat that makes it easy to achieve good blood sugar levels.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
6. I plan my meals.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
7. I use healthy diabetic recipes to prepare my meals.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
8. I exercise 15 to 30 minutes at least 3 times a week.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
9. I keep all of the appointments recommended for my diabetes treatment.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
10. I use a diabetes app to help educate me on diabetes and health issues associated with diabetes.
1= strongly disagree 2= disagree 3= neutral (neither agree or disagree) 4= agree 5= strongly agree
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Letter of Support for the Site
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Appendix E
Collaborative Institutional Training Initiative Certificate of Successful Completion
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Appendix F
IRB Approval

March 14, 2019

Fred Allen Smith Jr
IRB Approval 3686.031419: Mobile-Based Technology App Used to Improve Self-Care Management of Patients with
Type 2 Diabetes Mellitus

Dear Fred Allen Smith Jr,

We are pleased to inform you that your study has been approved by the Liberty University IRB. This approval is
extended to you for one year from the date provided above with your protocol number. If data collection proceeds past
one year or if you make changes in the methodology as it pertains to human subjects, you must submit an appropriate
update form to the IRB. The forms for these cases were attached to your approval email.

Your study falls under the expedited review category (45 CFR 46.110), which is applicable to specific, minimal risk
studies and minor changes to approved studies for the following reason(s):

2. Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows:
a. from healthy, nonpregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn
may not exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per
week; or
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from other adults and children [2], considering the age, weight, and health of the subjects, the collection
procedure, the amount of blood to be collected, and the frequency with which it will be collected. For these
subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and
collection may not occur more frequently than 2 times per week.

7. Research on individual or group characteristics or behavior (including, but not limited to, research on perception,
cognition, motivation, identity, language, communication, cultural beliefs or practices, and social behavior) or research
employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality
assurance methodologies. (NOTE: Some research in this category may be exempt from the HHS regulations for the
protection of human subjects. 45 CFR 46.101(b)(2) and (b)(3). This listing refers only to research that is not exempt.)

Thank you for your cooperation with the IRB, and we wish you well with your research project.

Sincerely,

G. Michele Baker, MA, CIP
Administrative Chair of Institutional Research
Research Ethics Office

Liberty University | Training Champions for Christ since 1971
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Appendix G
Consent Form
The Liberty University Institutional Review Board has approved this document for use from 3/14/2019 to 3/13/2020 Protocol #
3686.031419
CONSENT FORM
MOBILE-BASED TECHNOLOGY APP USED TO IMRPOVE SELF-CARE MANAGEMENT OF PATIENTS WITH TYPE 2
DIABETES MELLITUS
Fred Smith Jr
Liberty University
School of Nursing

You are invited to participate in a scholarly research project. You were selected as a possible participant because you are between the
ages of 19-70, have type two diabetes mellitus (T2DM) for greater than six months, English speaking, have access to an Android or
iOS device, and have had a referral to the diabetic educator within the last 12 months. Please read this consent form and ask any
questions you may have before agreeing to be in the study. Fred Smith Jr, a doctoral candidate in the School of Nursing at Liberty
University, is conducting this scholarly project.
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Background Information: The purpose of this scholarly project is to determine if the utilization of the Diabetes app will decrease the
hemoglobin A1c in patients diagnosed with T2DM in the underserved patient population. Furthermore, the development of the
Diabetes app aims to provide the underserved patient population with full-time access to improve self-care management techniques
and diabetic education to improve their hemoglobin A1c.

Procedures: If you agree to be in this study, I would ask you to do the following things:
1. During your normal appointment, you will be asked to have your hemoglobin A1c drawn, fill out a 10-question diabetic
questionnaire, demographic form, and be provided access to the custom Diabetes app. The app is FREE of charge to all
participants in this study. Estimated time to complete this procedure is 30 minutes.
2. Participants will be provided a detailed explanation of the Diabetes app in person during their first hemoglobin A1c draw by
the project team leader (Fred Smith). Participants will receive two push notifications each day, one at 8am and one at 5pm,
with helpful self-care management tips. Participants will be asked to utilize the Diabetes app daily during a three-month
period. Participants are asked to utilize the Diabetes app daily during the three-month study period.
3. Following the three-month window participants will take the same 10 question diabetes questionnaire again and have their
hemoglobin A1c drawn during their normal three-month chronic care appointment at BFP. Estimated time to complete this
procedure should take about 20 minutes.
4. Data will be pulled from each user’s activity during the three-month period. User data studied will consist of screen time of
each user and actions within the app.

Risks: The risks involved in this study are minimal, which means they are equal to the risks you would encounter in everyday life.

Benefits: The Diabetes app will serve as an education hub for all study participants. The Diabetes app will consist of dietary food
options, recommended exercise regimens, blood sugar log, diabetic education in congruence with the American Diabetes Association,
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and self-care techniques for diabetes management. In addition, the goals of increased self-care management should improve patient’s
hemoglobin A1c outside of traditional diabetic educational methods. Increased availability of disease management techniques endorse
better chronic disease management. Better management of diabetes prevents further associated complications of uncontrolled diabetes
such as diabetic neuropathy, diabetic retinopathy, heart disease, kidney disease, and overall shorter lifespan.

Benefits to society may include: Technology supports self-care management by providing patients the ability to have blood glucose
monitoring, dietary recommendations, medication adherence, and user platform discussion forums. The utilization of mobile app
technology improves barriers to healthcare access, improves patient education, and increases patient exposure to self-care
management techniques. Healthcare providers should incorporate the utilization of mobile-based technology to effectively manage
T2DM. Better short term and long-term management of T2DM will reduce associated costs of complications with ineffective T2DM
management. Potentially an estimated 327 billion dollars could be saved in estimated healthcare costs associated with T2DM
complications.

Compensation: Participants may be compensated for participating in this study. All study participants will have the opportunity to
have their name placed in a drawing to win a 19inch television. This number of times each participant is based on who has the highest
app utilization, fastest study enrollment, and overall highest hemoglobin A1c decrease (three ways to boost entry count). Every day
participants that login the Diabetes app they will be given one entry, for a maximum of 90 entries (1 entry potentially each day for 90
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days). Participants that sign consent within three days will receive 50 additional entries to their grand total. In addition, the
participant with the overall highest hemoglobin A1c decrease will receive an additional 100 entries at the end of the study. All study
participants based on the previously mentioned criteria will have their entries totaled and randomly selected at the end of the study
during a drawing. The winning participant must complete the entire study time of three months and must complete all before and after
questionnaires for the study to receive the 19-inch television.

Confidentiality: The records of this study will be kept private. In any sort of report or presentation I might publish, I will not include
any information that will make it impossible to identify subjects. Any information gathered from the app utilization will be protected
under encrypted codes within the app (private app). All information will be encrypted with no personal information related to study
participants. There will be no interactions with other users. All feedback from potential users will be sent directly to the project team
leader email or cell phone. The Diabetes app is exclusively available to only participants associated with this study. Research records
will be stored securely, and only the researcher will have access to the records. I may share the data I collect from you for use in
future studies or with other researchers; if I share the data that I collect about you, I will remove any information that could identify
you, if applicable, before I share the data.




Participants will be assigned a randomized number.
Data will be stored on a password locked computer and may be used in future presentations. After three years, all electronic
records will be deleted in accordance with federal law.
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All data collected and gathered from the Diabetes app will be stored and secured with an encrypted login and private secure
database. This app is made private, and only available to involved study particpants. Data will be sent to previously mentioned
above password locked computer and may be used for future presentations. After three years, all electronic records will be
deleted in accordance with federal law.

Voluntary Nature of the Study: Participation in this study is voluntary. Your decision whether or not to participate will not affect
your current or future relations with Liberty University or Bassett Family Practice. If you decide to participate, you are free to not
answer any question or withdraw at any time.

How to Withdraw from the Study: If you choose to withdraw from the study, please contact the researcher at the email
address/phone number included in the next paragraph. Should you choose to withdraw, data collected from you will be destroyed
immediately and will not be included in this study.

Contacts and Questions: The researcher conducting this study is Fred Smith Jr. You may ask any questions you have now. If you
have questions later, you are encouraged to contact him at 336-837-5190 or fsmith23@liberty.edu. You may also contact the
researcher’s faculty chair, Dr. Moore, at vbmoore@liberty.edu.

MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT

90

If you have any questions or concerns regarding this study and would like to talk to someone other than the researcher, you are
encouraged to contact the Institutional Review Board, 1971 University Blvd., Green Hall Ste. 2845, Lynchburg, VA 24515 or email
at irb@liberty.edu.

Please notify the researcher if you would like a copy of this information for your records.

Statement of Consent: I have read and understood the above information. I have asked questions and have received answers. I
consent to participate in the study.

______________________________________________________________________________
Signature of Participant

Date

______________________________________________________________________________
Signature of Investigator

Date

MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT
Appendix H
Demographics Questionnaire
Please answer the following questions below: (Any section may be left blank)

Age:
Sex:
Race:
Highest level of education:
Household income:
Years of diabetes:
Home diet:
Current diabetic medication:

All information is kept confidential and encrypted
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Likert Scale Ranking Score Diabetes Questionnaire
Total score as follows:
20 or below Bad (high risk complications)
25-20 Poor
30-25 Below-Average
30-40 Average
40-45 Good
45-50 Great
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Appendix J
Instructions for Diabetes App:

1. Please turn on phone
2. Please locate markets for your service provider (App store for iOS users), (Android marketplace for Android
users)
3. Please type in the search engine “Diabetes app
4. Please locate free version
5. Login with user email and create password
a. For Apple users you may utilize your Face ID to sign in for your password, or thumbprint on older models
once your password is created
b. For Android users you will have to set up with an email and password.
6. Once logged in you will be taken to the home screen. Please click the in app mobile widget named “Welcome”
a. Inside the welcome function you will watch an introductory video, purpose of this scholarly project, and
will receive step by step instructions on how to use each function from team leader Fred Smith Jr DNP
candidate.
7. If you encounter any problems with gaining access to the welcome screen, please contact the app developer
Fred Smith.
a. Contact any time with questions at 336-837-5190 or email any questions to fsmith23@liberty.edu. You will
receive a response within 24-hours
8. I hope you enjoy this app!
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Appendix K
Timeline of the Scholarly Project
Completion

Planning

Date
7/31/2018

Meet with Scholarly
project chair to present
idea and project
development

8/30/2018

Receive approval from
scholarly project chair,
then identify key stake
holders individually to
obtain their support and
organization endorsement.

Pre-Implementation

Implementation

Evaluation
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8/30/2018

First meeting with clinical
director and organization
providers to present ideas
for project.

9/30/2018

Receive verbal
endorsement of letter of
support from Bassett
Family Practice clinical
director.

10/30/2018

Began and draft preproposal for IRB
submission

11/1/2018

Pre-screen 60 participants
who meet inclusive criteria
for the project
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Submit pre-proposal to
scholarly project chair

1/16/2019

Perform mini-presentation
to scholarly project chair

1/20/2019

Submit IRB application

2/20/2019

Develop app with Appy
Pie software

2/20/2019-

Receive IRB approval

3/1/2019
3/1/2019

Develop Diabetes App for
Android and iOS platforms

3/15/2019

Launch 5 beta testers of
app

2/20/2019-

Obtain consent for 60

3/20/2019

participants, and instructions on
how to utilize mobile app,
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implement diabetes
questionnaire and
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Implement utilization of
Diabetes app for scholarly
project for three-month period

3/25/2019

Start two-push notifications
daily for enrolled participants
during three-month period

6/25/2019

Conclude three-month scholarly
project Diabetes app and
distribute post survey.

6/25/2019

Utilize SPSS
software to analyze
data, prepare
presentation

7/15/20198/1/19

Present data

